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GENERAL INTRODUCTION 
 
Thesis organization 
This thesis is organized as follows.  The 1st chapter is a brief discussion of the 
concepts of evidence-based medicine (EBM) and their potential for application to agri-
food arena.  The 2nd chapter is a brief background discussion of Salmonella in swine 
focusing on pre-harvest interventions available for controlling Salmonella.  The 
subsequent chapters 3, 4, and 5 are examples of approaches used over the past 18 months 
to apply EBM principles to Salmonella in swine. Chapter 3 “Efficacy of vaccination to 
reduce Salmonella prevalence in live and slaughtered swine: a systematic review of 
literature from 1979 to 2007” is a systematic review of vaccine interventions for 
Salmonella and illustrates the application of the evidence pyramid and systemic review 
approach to Salmonella in swine.  Chapter 4 “A review of antibiotics to reduce 
Salmonella in swine: a quantitative analysis of binomial and continuous data” illustrates 
the application of the evidence pyramid and systemic review approach including meta-
analysis for continuous and categorical data to Salmonella in swine.  Chapter 5 
“Evaluating the sensitivity and specificity of PCR and culture method for detection of 
Salmonella in field samples using the STARD approach”, a diagnostic test evaluation 
study for Salmonella PCR and culture, illustrates the use of application of EBM 
statements study design, in particular, the STARD statement.  The final discussion 
concludes the significance and impact of research findings of the present study. 
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CHAPTER 1  
AN INTRODUCTION TO EVIDENCE-BASED APPROACHES TO 
VETERINARY SCIENCE AND FOOD SAFETY: APPLICATION TO 
SALMONELLA IN SWINE 
 
Evidence-based medicine (EBM) is an area of clinical medicine that uses aims to 
combine the best scientific evidence with practical experience to make the decision about 
a patient’s outcome. The concept has been used in human medicine for the past 15-20 
years and has expanded in include areas of evidence-based public health and evidence 
based nursing.  
In veterinary science and food safety, recent publications have discussed the need 
for evidence-based approaches to study design and literature review in agri-food public 
health to make informed decisions for food safety policy makers and other decision 
makers in food production continuum (Sargeant et al., 2006a; Sargeant et al., 2006b).     
The idea of formalizing the evidence-based approach to decision making is therefore 
relatively new to veterinary science and food safety. Veterinary science and food safety 
differ greatly from clinical medicine in many important areas including the unit of 
concern, i.e. individual versus groups, prevention of outcomes rather than treatment of 
disease, the influence of publication bias and the availability of challenge models to 
assess outcomes. Therefore, translation of EBM concepts to veterinary science and food 
safety will require careful consideration of what is applicable and when are changes 
needed for these unique fields.   
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Central to the concept of EBM is the idea that some information sources have 
greater evidentiary value and greater weight should be given to information obtained 
from higher quality information sources.  A common information source is results from 
primary research studies, and central to EBM is the concept that individual studies should 
be reported in such a way that the quality of the study can be assessed.  Further, when 
evaluating a body of work to reach a decision about treatment or intervention, the study 
design and the quality with which it was executed should be a consideration, and greater 
weight given to results obtained from well executed high quality designs. To promote 
these concepts, there are three primary tools in clinical EBM;  
1) an evidence pyramid that described the hierarchical value of information 
sources 
2) a series of statements that describe the elements within a study design that 
should be reported so that quality can be assessed and  
3) a formal structure for incorporating 1 and 2 when evaluating a body of work 
i.e. systemic reviews which may include meta-analysis.  
These tools have been designed for assessment of human therapy purposes.  The 
purpose of this thesis has been to explore how these tools can be applied and issues 
associated with that application, to the food safety decision arena. The test base for the 
application is pre-harvest prevention of food borne disease associated with Salmonella in 
swine.  
1) The evidence pyramid in human medicine  
 An evidence pyramid provides the framework for ranking information sources 
that evaluate health care interventions (Figure 1). The most clinically relevant study 
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designs are located at the top of the pyramid and the least clinically relevant sources such 
as in-vitro test tube studies are at the bottom of the pyramid. The value of evidence 
provided by an information source is associated with statistical power and potential for 
bias, with the quality of the individual studies critically evaluated. The statistical power 
of a study is dependent on sample size, magnitude of the effect of the intervention and the 
natural variation (Cockcroft and Holmes, 2003). The potential for bias such as 
confounding, selection and misclassification bias in an information source is higher in 
studies in lower positions on the pyramid.  For example, when addressing therapy 
questions, randomized controlled trials (RCT) provide the best opportunity for examining 
effectiveness of interventions, as random allocation to treatment groups under natural 
conditions minimizes the potential for confounding bias compared to cohort studies and 
case-control studies. Further, based on EBM concepts, a large well-executed RCT would 
provide better evidence than a small well executed RCT. The highest form of evidence 
for a therapy is a systemic review with meta-analysis, which is a combination of several 
RCT with the same therapy and disease classification.  A combination of well-executed 
RCT is considered better evidence than a single well-executed RCT because the potential 
impact of bias will be less and the number of unit studies is higher.  
Challenges for veterinary science and food safety 
There are numerous examples of RCTs available in human medicine for a specific 
question to be addressed in a systematic review. But, in veterinary medical context, 
specifically in on-farm intervention strategies RCTs are rare and research evidence 
primarily comes from observational studies such as cohort studies, case control studies 
and cross-sectional studies. Observational studies are easy to conduct in commercial 
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livestock production systems than the experimental RCTs. These study designs are useful 
for addressing issues about causation. Cohort studies and case control studies are useful 
for testing hypothesis, and cross-sectional studies are used to generate hypothesis. The 
hierarchy of evidence in the human evidence pyramid is limited to the available medical 
literature. In the absence of randomized controlled trials in veterinary science and agri-
food research, there is a need to understand the evidentiary value of available research in 
these fields, and rank in the evidence pyramid.  
Another unique characteristic of veterinary science and food safety is the 
challenge study design, an experimental study design that uses artificial inoculation of the 
animal with the disease agent (Sargeant et al., 2006b). Challenge studies provide the 
evidence of effectiveness of intervention under controlled conditions in the species of 
interest, but not under naturally occurring commercial setting with natural disease 
infection.  In human therapy, this design is not available, and experimental challenge 
models are rated very poorly because the natural environment is missing and the species 
is not human. In veterinary science and food safety what value should this design have? It 
is unclear how this design should be valued as although the ability to experimentally 
infecting the species of interest is important, the absence of the natural environment is a 
serious limitation.  Veterinary science has many examples of intervention efficacy under 
laboratory conditions in the species of interest that have not translated into field efficacy.  
Challenge study outcomes may not reflect field outcomes for many reasons 
including the multi-factorial nature of disease and the clustering of animals in agriculture.  
Agricultural animals can be grouped into litters, pens, barns or lots within a commercial 
operation. Therefore, when applying interventions, the effect of animal clustering should 
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be considered. Most often challenge studies and even RCTs studies are conducted using 
small number of animals or groups, and limiting the findings of these studies to the 
commercial settings.  
Publication bias refers to the higher probability of studies with positive results 
being published, and it is well known that only a proportion of research projects 
ultimately reach publication in peer reviewed journals (Egger et al., 2001). Publication 
bias occurs when sponsors do not allow studies unfavorable to their products to be 
published or allow only selective reporting of favorable studies. A condition of this 
funding is that data are owned by the firm and this may lead to publication bias more 
frequently in challenge trials than in observational research where the presence of 
industry is much limited. Other potential forms of publication bias include publishing 
funded research in supplements as proceedings of symposia. Researchers have raised 
concerns that studies with negative results may remain unpublished and their failure to 
appear in the literature can distort the conclusions that we obtain from clinical 
experiments regarding the best available evidence. Perhaps, this is a major concern in the 
field of veterinary science and food safety intervention studies since research in these 
areas get less government funding than the relevant human medicine research. Also, in 
human medicine, it is necessary to register all government funding research trials in 
clinical trial register in the United States (Anonymous, 2008a). But, there is no obligation 
to register privately funded trials in veterinary science and food safety research studies. 
Therefore, if evaluating only peer-reviewed literature might have the potential to distort 
evidence, and hence food-safety policy.  
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2) A series of statements that describe the elements within a study design - 
CONSORT statement and STARD statement  
 To improve the quality of reporting for studies, several standardized statements 
for reporting studies in human medicine have been developed; the consolidated standards 
of reporting trials (CONSORT) statement, the standards for the reporting of diagnostic 
accuracy studies (STARD) statement, and the reporting of meta-analysis of observational 
studies in epidemiology (MOOSE).  
The first and most widely known statement is designed for RCTs, the 
consolidated standards of reporting trials (CONSORT) statement.  which  comprises a 
checklist and flow diagram for reporting a RCT  (Begg et al., 1996; Moher et al., 2001). 
The CONSORT is primarily intended for use in writing, reviewing or evaluating reports 
of RCT, although it is frequently used as a tool for designing RCT.  The aim of the 
CONSORT is to allow readers to assess the execution of the study design, and therefore, 
the evidentiary value of the results.  The CONSORT statement checklist helps 
researchers write a clear and comprehensive report of the RCT while the flowchart helps 
the scientist and readers follow participants or subjects through the RCT. Using the 
checklist provided by the CONSORT, readers can determine if adequate information is 
given to assess the study execution, and based on that assessment the applicability and 
validity of the trial results.  In theory, at least, if a trial is in adequately reported, the 
results are not given further consideration. The CONSORT statement has been adopted 
by more than 150 medical, clinical and psychological journals, and has been translated 
into several different languages (Anonymous, 2008b).  
  
8 
The CONSORT statement and checklist is primarily focusing on RCTs. 
Application of CONSORT statement and checklist to veterinary science and food safety 
intervention studies is limited since the lack of such trials. It is possible to modify and 
adopt such statement for veterinary science and food safety intervention studies by 
modifying the checklist to fit for the challenge studies and observational studies. So far, 
CONSORT statement has been endorsed by only two journals that publish research 
articles related to veterinary science; The Veterinary Journal and The Equine Veterinary 
Journal (Anonymous, 2008b).  
Another example of a standardized statement is the STARD which related to 
studies of diagnostic tests. Studies of diagnostic tests are required to validate new 
diagnostic tests before they are introduced into practice. These studies typically report 
sensitivity and specificity, likelihood ratios, or area under a receiver operating 
characteristics (ROC) curve as measures of diagnostic performance. Using this 
information enables judgments to be made relating to the potential suitability of new tests 
for clinical practice. However, improperly conducted and incompletely reported studies 
are likely to include bias that in turn, may lead to overly optimistic estimations of the 
diagnostic value of the test. Exaggerated results may lead to premature adoption of 
diagnostic tests and to incorrect clinical decisions. To improve the quality of reporting of 
diagnostic accuracy studies, the STARD statement consist of a checklist of 25 items and 
it is recommended to use of a flow diagram which describes the design of the study and 
the flow of patients (Bossuyt et al., 2003). This allows improving the accuracy and 
completeness of reporting of studies of diagnostic accuracy, to allow readers to assess the 
potential for bias in the study and to evaluate its generalisability to the external 
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populations. One of the ultimate benefits for using the STARD initiative is to develop a 
consistent reporting format across all types of diagnostic tests and clinical disciplines. 
STARD statement and check list has been adopted by many leading medical 
journals (Anonymous, 2008c). So far, veterinary journals that publish diagnostic test 
accuracy studies have not adopted the STARD statement. Reporting diagnostic test 
accuracy studies related to veterinary science and food safety interventions with deficient 
information will lead to adopt inaccurate diagnosis tests by practitioners and producers. 
This may result in unhygienic food available in the market for human consumption.  
3) A formal structure for incorporating the hierarchy of information sources and 
the quality of design execution when evaluating a body of work 
 EBM uses a very formal approach to incorporate the key EBM concepts into 
decision making, and this approach is referred to as systemic review.  
Systematic reviews  
Systematic reviews are focused on specific review questions and for clinical 
human medicine; this is usually about the efficacy of a treatment for a particular 
condition in a subgroup of the population.  The systematic review process describes 
procedures for obtaining primary research papers that will be considered for answering 
the review question, assessing the quality of conduct of primary research, and when 
appropriate, synthesizing data quantitatively. The purpose of these procedural details is to 
increase the transparency of the review and allow readers to assess the potential for bias 
to influence the review conclusions, as they would on primary research using the 
standardized reporting guidelines. In fact, there is a standardized reporting guideline for 
systemic review (Begg et al., 1996; Moher et al., 2001; Stroup et al., 2000)  
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Assessment of methodological quality such as design, conduct and analysis of 
studies included in systematic review to evaluate the overall strength of evidence is a 
major departure from the traditional narrative review. Consistent with EBM the aim is to 
reproduce review, if the reader followed the procedure details in the systematic review. 
For example, if the systemic review describes a search of PubMed with particular terms 
and date restrictions, a reader should be able to reproduce the search results. The systemic 
review process does not prevent bias, but aims to enable readers to identify bias. For 
example, if a systemic review identified a PubMed search, and the reader notices a 
critical term is missing, then the reader can identify a bias. In a narrative review, with no 
search terms published, the reader cannot identify the bias.  
The characteristics of narrative versus systematic reviews are listed in Table 1. 
Narrative reviews often focus on a wide range of objectives, without a clear question and 
therefore may not provide clarification about the review process. Therefore, traditional 
narrative reviews are often biased. In contrast to the narrative reviews, systematic reviews 
critically appraise a specific clinical question using explicit methods in a transparent 
manner allowing reproducibility. Therefore, systematic reviews are less likely to have 
biases in the selection of studies. Assessment of methodological quality of studies in 
systematic reviews provides overall strength of the evidence. Systematic review allows 
scientists to establish whether findings are consistent and generalizable across 
populations, or whether findings are varied significantly by particular sub group 
(Akobeng, 2005; Sargeant et al., 2006a).  
Two primary factors have been the motivators for the development of systematic 
approaches to translating and summarizing a body of scientific literature. First, more than 
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two million biomedical articles are published annually in over 20,000 journals.  This 
massive amount of information necessitates a compression of information. This role can 
be filled by narrative or systematic reviews.  However, in the early 80’s, critical analysis 
of medical reviews indicated that these reviews did not routinely use scientific methods 
to identify, assess and synthesize information, i.e. the reviews were not subjected to the 
scientific process of repeatability. It is obvious that review authors were weighing the 
value of studies differently or using different methods to identify literature, therefore, the 
methods differed between reviews, but these methods were not reported. The first attempt 
to address this issue was a review which reported standard factors that should be included 
in a review i.e. standard reporting guidelines (Mulrow, 1987). This movement also later 
included the “MOOSE” statement for how to report reviews (Stroup et al., 2000).  
Current to this process of “how “ to report a review, was the EBM movement 
which address the 1st major difference between reviews i.e. authors giving different 
weight to studies. The evidence based movement, recognized that different studies and 
study design features increase the value of information obtained. In evidence based 
medicine, the greatest statistical certainty comes from meta-analyses that incorporate a 
number of RCTs.  
The combination of trying to make “reviews” repeatable and weighing the values 
of studies consistently within a review represents the key features of a systemic review 
and several organizations became in outlining the methodologies required for a 
systematic review. The most important of these are Cochrane Collaboration, BMJ 
evidence-based medicine group, Campbell Collaboration, NHS Centre for Reviews and 
Dissemination, and US centers for Evidence-Based Medicine which are all involved in 
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coordinating systematic review methodology in medical field. Since the beginning of 
90’s, systematic reviews have been well established for health care providers, researchers 
and policy makers to efficiently integrate existing information and provide data for 
rational decision making (Cook et al., 1997; Mulrow, 1994).  
 Another aspect of EBM with the concept of systematic reviews is meta-analysis. 
In many cases, individual studies often failed to detect significant difference between two 
treatments due to inadequate sample size. On the other hand, it is not economical or 
practicable to conduct large studies. An alternative to such large studies is to conduct 
meta-analysis using similar studies to address a specific question (Egger et al., 2001). 
Meta-analysis is the process synthesizing research results by using various statistical 
methods to retrieve, select and combine results from separate but related studies, and to 
investigate reasons for variations among studies. In meta-analysis, weighted averages of 
effects are combined to make summery estimate, so that larger studies have more 
influence than smaller studies taking into account both individual estimates and their 
standard errors (Dohoo I et al., 2003; Egger et al., 2001). If the treatment effect is 
consistent among various strata of the population, generalisability of scientific findings 
can be established. The other advantage of meta-analysis is to increase the statistical 
power specifically in studies with relatively low incident rates, and small effect sizes are 
being assessed (Mulrow, 1994). Cumulative meta-analysis is the process of repeating 
meta-analysis whenever new studies become available to include for the previous meta-
analysis. Thereby, increasing the sample size results in narrowing of confidence interval 
so that precision of the estimates become increased if the new treatment appears to be 
significantly effective.  It is possible to conduct meta-analysis on a group of studies 
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without considering their evidentiary value, therefore, meta-analyses are not unique to 
EBM or systematic reviews, and however they are a common feature.  
Very few systematic reviews related to veterinary science have been published in 
peer-reviewed journals. Because of scarcity of RCT in the field of veterinary science and 
food safety intervention studies, researchers need to identify other study design that are 
available to address issues related to food safety. The required information may not be 
available in published journals. Therefore, searching for unpublished studies, expert 
opinion, expert reports and conference proceedings may help to identify available 
information.   
Conclusion  
The general aim of this thesis has been to apply some of the concepts of EBM to 
veterinary science and food safety using interventions designed for pre-harvest 
interventions in Salmonella in swine. Research is conducted so that science may reduce 
our uncertainty about the outcome and decisions. Individual research papers contribute a 
small amount to understanding. However, scientists should be able to evaluate a body of 
work on a topic and report what the body of work is “telling us”.  This formal approach 
to the evaluation of a body of work is a relatively new field in veterinary science and 
food safety. The aim is to translate the body of work into a format that makes it 
consumable by the end user. There are many methods of translating a body of scientific 
literature for decision makers such as risk assessment, expert opinion, narrative review, 
meta-analysis and the approach evaluated in this thesis i.e. systematic review which may 
include meta analysis. 
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Table 1. Differences between traditional narrative reviews and systematic reviews 
describing essential features of these reviews. 
Essential feature Traditional narrative review Systematic review 
1. Review question Often broad in scope Often a focused clinical question 
2. Literature sources & 
search strategy 
Usually not provided Comprehensive search of multiple 
databases and explicit search strategy 
provided  
3. Selection of studies  Usually not provided, 
potentially biased 
Criterion-based selection process 
uniformly applied 
4. Review and appraisal Varies, depend on the reviewer  Rigorous critical appraisal  
5. Study quality No formal quality assessment Always quality assessment included 
6. Data synthesis Often a qualitative summary Qualitative and quantitative if the 
data can be pooled 
7. Inference Sometimes evidence-based Typically evidence-based 
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Figure 1. The hierarchy of evidence illustrated as a pyramid of evidence in EBM. The 
most clinically relevant, strongest evidence are at the top of the pyramid and gradually 
become weaker towards the bottom of the pyramid.  
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CHAPTER 2 
 AN INTRODUCTION TO THE TEST BASE AREA: SALMONELLA IN SWINE 
AS A FOODBORNE PATHOGEN 
 
  Salmonella is a zoonotic pathogen capable of colonizing many vertebrates. 
Infection due to Salmonella in human and domestic animals remains a serious worldwide 
problem, and the outcome of the infection varies from asymptomatic carrier stage to 
serious systemic infection. Salmonella infection in animals are of importance due to the 
direct economic consequences of mortality and morbidity associated with clinical 
disease, and due to human health consequences of salmonellosis acquired by direct or 
indirect contact with animals or animal products. These consequences have resulted in 
increased efforts in many countries to reduce the prevalence of Salmonella in food-
producing animals.  
 
Nomenclature of Salmonella 
 The genus Salmonella consists of a taxonomic group that contains over 2500 
recognized serotypes (serovars) (Popoff et al., 2004; Popoff and Le Minor, 1997). There 
are two species of Salmonella: S. enterica and S. bongori. The species S. enterica is 
divided into six subspecies:  enterica, salame, arizonae, diarizonae, houtenae, and 
indica. About sixty percent of serovars of Salmonella belong to S. enterica sub species 
enterica, and these are present in avian and mammalian hosts.  S. enterica sub species 
enterica contains all serovars that cause disease in domestic animals and human, and only 
less than fifty serovars account for most of the cases of disease in animals and humans.  
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Characteristics of S. enterica 
 Salmonella, a member of the family Enterobacteriaceae are facultative anaerobic 
non spore forming, gram-negative rods. Most isolates grow optimally at 37º C, however, 
salmonellae can grow between 7º C and 48º C. Growth can also occur between pH 4 to 8. 
Salmonellae are readily killed by heat and acid, but can survive freezing and drying. The 
ubiquitous presence in animals and environment make salmonellae one of the most 
important foodborne pathogens in the United States (Baird-Parker, 1990).  
With the exception S. enterica sub species arizonae and diearizonae, all the other 
Salmonella are non-lactose fermenting. A common distinguishing family characteristic is 
the ability to produce acid through fermentation of glucose (Cowan, 1974). Salmonella 
are negative in the indole, Voges-Proskauer and urease tests, and positive in methyle red, 
citrate utilization, H2S production, lysine decarboxylation, and ornithine decarboxylase 
tests. Recovery of Salmonella from fecal or environmental samples is often required to 
diagnose disease or to identify sources of infection in animals. These samples usually 
contain a large number of non-Salmonella bacteria and thus isolation of Salmonella 
requires inhibition of non-Salmonella bacteria while ensuring the growth of Salmonella 
(Libby et al., 2004). Therefore, combination of many pre-enrichment, selective 
enrichment and indicative plating are required to identify Salmonella in these samples.    
  
Salmonella in swine and food safety 
In swine, several Salmonella serotypes are frequently isolated from clinical and 
non-clinical animals.  Infection with serovar Typhymurium of S. enterica is associated 
with enterocolitis and often develops a carrier state in swine (Fedorka-Cray et al., 1995). 
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Many serotypes of S. enterica are responsible for illness in human (Centers for Disease 
Control, 2005) (Table 1). The four serotypes mostly found in human cases in United 
States from 1970 to 2005 are S. Typhimurium, S. Enteritidis, S. Heidelberg and S. 
Newport (Centers for Disease Control, 2005). Of the top twenty serovars most commonly 
associated with human infections, four serovars (S. Typhimurium, S. Heidelberg, S. 
Agona, and S. I 4,[5],12:i:-) are also found among the top serovars of swine (Table 2) 
during the year 2005 (Centers for Disease Control, 2005). 
 
Foodborne salmonellois: clinical disease in humans  
In 1999, it was estimated that 1.4 million cases of human salmonellosis occurred 
in the United States annually, resulting more than 15,000 hospitalizations and over 500 
deaths. S. enterica is considered as the second most important cause of bacterial 
foodborne disease in the United States (Mead et al., 1999). The number of reported cases 
of Salmonella in humans in Europe in 2005 was greater than 175,000, and the estimated 
number of unreported cases was several folds higher than the reported cases (European 
Food Safety Authority (EFSA), 2005). In the United States, 36184 human Salmonella 
cases has been reported to Centers for Disease Control (CDC) during the year 2005 
(Centers for Disease Control, 2005). The under-reporting of Salmonella has been 
estimated 38 times higher than the reported cases in the United States (Chalker and 
Blaser, 1988). The main reservoir of non-typhoidal Salmonella is food animals, and the 
main sources of infections in developed countries are food of animal origin, mainly, 
poultry, pork, beef and eggs (Mayrhofer et al., 2004; Rose et al., 2002; Sanchez et al., 
2002). It is estimated in Europe that 9 to 15% of human Salmonella cases are estimated to 
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be due to pork (Hald et al., 2004). Accordingly, in order to reduce the potential risk to 
consumers by Salmonella contaminated food, it is crucial to reduce the pathogen load 
intake into the food chain.  
On farm S. enterica fecal prevalence is reported to be around 3.4% compared to 
71.8 % at the abattoir-collected samples from market swine slaughtered in Iowa (Hurd et 
al., 2001). In another study, there was sevenfold-higher S. enterica isolation rate from 
pigs slaughtered at the abattoir (39.9%) compared to those slaughtered on the farm 
(5.3%) (Hurd et al., 2002). Therefore, it appears to be 40-70% of market swine are 
positive for S. enterica at the abattoir compared to 3-5% on-farm prevalence.  However, 
the fecal isolation of S. enterica serotypes from naturally contaminated swine differs 
among culture methods (Rostagno et al., 2005). Prevalence estimates of individual 
studies are an important tool to evaluate the presence of Salmonella at a point in time, 
and provide information for control strategies.  
 
Culture methods for Salmonella 
 A three-stage procedure involving pre-enrichment in non-selective broth, 
enrichment in selective broth, and subsequent detection on selective and indicative agar 
media is required to detect Salmonella in samples with low initial cell numbers or with 
bacteria those are stressed due to physical or chemical injury. Pre-enrichment broths 
available are buffered peptone water, lactose broth and brilliant green broth lauryl 
tryptose broth, manitol purpal suger broth, and nutrient broth can also be used  (Hoorfar 
and Baggesen, 1998). This procedure is used on environmental and food samples and 
fecal and tissue samples from animals without clinical disease. Enrichment broths 
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recommended for Salmonella isolation are tetrathionate and Rappaport-Vassiliadis (RV) 
(Hammack et al., 1999; U.S.Food and Drug Administration, 1998). Selective enrichment 
with RV is generally carried out at 42º C for 24 hours. Selective and indicative media 
used for salmonellae are Salmonella-Shigella (SS) agar, bismuth sulfite (BS) agar, and 
xylose lysine desoxycholate (XLD) agar, brilliant green (BG) agar and desoxycholate 
citrate agar. MacConkey agar, Hektoen Enteric (HE) agar desoxycholate agar, and eosin-
methylene blue (EMB) agar are less selective but primarily differential. Typical growth 
characteristic of Salmonella on commonly used selective and differential media are listed 
in Table 3.  
Once potential salmonellae are identified, biochemical profiling and serological 
testing are performed for confirmation. A battery of biochemical tests recommended for 
further confirmation of Salmonella. (U.S.Food and Drug Administration, 1998). The 
majority of biochemical tests are incorporated by inoculation into triple sugar iron (TSI) 
and lysine iron agar (LIA) followed by incubation for 18 to 24 hours at 37º C (Davies et 
al., 2000; Waltman et al., 1991). Once an isolate is confirmed as Salmonella, serological 
testing is carried out with commercially available Salmonella ‘O’, ‘H’ and ‘Vi’ 
antibodies. Serotyping based on Kauffman-White scheme requires two consecutive 
agglutination tests. First, ‘O’ antigen is identified in a slide agglutination test by mixing a 
saline suspension of bacterial cells mixed with different anti ‘O’ sera. Subsequently, ‘H’ 
antigen is determined by use of formalin killed broth culture mixed with different anti ‘H’ 
sera in tube agglutination test. To confirm the specific antigens in ‘O’ and ‘H’ test, 
absorbed single-factor anti-sera are used (Brenner et al., 2000). For epidemiological 
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purposes, Salmonella serotypes are further differentiated by phage typing which is based 
on reactivity with a defined set of bacteriophages.  
 
Rapid detection techniques 
 The relative insensitivity and time consuming nature of routine culture and 
biochemical methods available for Salmonella isolation and identification prompted 
researchers to develop rapid methods such as serological and genetic techniques. Most of 
these rapid methods that detect Salmonella antigen/s still necessitate culturing Salmonella 
until the cell numbers reach a range of 104 to 105 cells per ml.  Therefore, most rapid 
antigen detection methods require 8 to 24 hours for completion although they are more 
convenient and less labor-intensive than the conventional methods (Molbak et al., 2006).  
 
Enzyme-linked Immunosorbent Assay (ELISA) to detect antibodies to Salmonella  
 This test is used for mass screening of past/present Salmonella-infected animals 
on herd basis.  The ELISA test is sensitive, cost effective, available for automation, and 
no prior incubation is required to increase the number of bacterial cells. The constraint 
with the test is that it is less useful for testing individual animals. Anti-Salmonella 
antibodies often appear only 1 to 2 weeks post-infection, and is always not indicative of a 
current infection (Hanes, 2003). This method is being widely used in Denmark, The 
Netherlands and in Germany in Salmonella pre-harvest control programs for poultry and 
pigs (Nielsen et al., 1998; Wiuff et al., 2000) . There are different types of ELISAs that 
utilize different Salmonella antigens.  One assay utilizes LPS of S. Typhimurium and S. 
Choleraesuis to detect antibodies to Salmonella O antigen (Nielsen et al., 1994). This 
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assay can be used at the herd level but not suitable to test individual animals. Another 
ELISA test uses heat-extracted antigen to detect antibodies in Salmonella carrier swine 
(Kramer et al., 1994). This ELISA was later developed to utilize a different type of heat-
extract antigen in mixed ELISA format to offer with a better sensitivity and specificity 
(Gray and Fedorka-Cray, 1999). Countries such as the USA, Germany, France, UK and 
the Netherlands have used different ELISA techniques that have been developed to detect 
Salmonella serovars prevalent in the country. In Denmark, the mixed ELISA has been 
used for routing screening of breeding, multiplying and slaughter swine herds (Nielsen et 
al., 2001).  
 
Enzyme-linked Immunosorbent assay (ELISA) to detect Salmonella antigens 
 There are a number of commercial kits available to detect Salmonella antigens. 
However, it requires prior pre-enrichment and selective enrichment to achieve enough 
Salmonella required for detection limit of the test (Swaminathan and Feng, 1994). Some 
ELISAs detect Salmonella antigens in swine feces, whereas, some other ELISAs are 
performed on swine lymph nodes and cecal contents (Araj and Chugh, 1987; Van 
Poucke, 1990). Sensitivity and specificity of these antigen ELISAs heavily depend on the 
cleanliness of the sample (Harvey et al., 1999).   
 
DNA-based detection methods 
A number of PCR techniques have been developed for the rapid detection of 
Salmonella in clinical samples (Nowak et al., 2007; Sibley et al., 2003; Stone et al., 
1994).  These techniques are based on amplification of targets such as replication genes, 
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fim genes and inv genes of Salmonella (Sibley et al., 2003; Stone et al., 1994)). One 
method that uses PCR amplification of 457-bp sequence covering invE and invA genes 
coupled with Southern hybridization was sensitive enough to detect about 9 CFU of 
Salmonella organisms in pure culture and 300 fg of purified chromosomal DNA.  When 
this PCR-hybridization assay was coupled with a brain heart infusion enrichment step for 
2 hours, it could detect as few as 80 CFU of Salmonella organisms in seeded feces (Stone 
et al., 1994). Most of the PCR assays had a low detection limit and detected Salmonella 
serovars in clinical samples with the same sensitivity and specificity as did the culture 
methods. However, these tests detected Salmonella more quickly than conventional 
culture techniques. Spiking of samples with appropriate serovars of Salmonella has been 
proved to increase the sensitivity of the PCR assays (Eriksson and Aspan, 2007). Recent 
attempts have been also made to develop and validate a LightCycler real-time PCR assay 
(LC-PCR) and a PCR-enzyme-linked immunosorbent assay (PCR-ELISA) for detecting 
Salmonella in meat samples (Perelle et al., 2004).  
Intervention strategies to reduce Salmonella in swine 
 Salmonella in swine is a high priority research area due to its impact on swine 
health and production as well as its ability to cause foodborne illnesses in human.  
Therefore, control of Salmonella in swine is important in both swine and public health 
standpoints.  Numerous intervention strategies have been attempted to reduce foodborne 
illness and economic loss to the swine caused by Salmonella.  Various intervention 
strategies which are being practiced to reduce Salmonella levels throughout the pork 
production system can be categorized under three broad areas: on-farm or pre-harvest 
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interventions, interventions during the processing or harvesting at the abattoirs, and post-
harvest interventions. On-farm intervention strategies include vaccination, management 
practices, type of feed, use of antibiotics, acids, prebiotics, probiotics, and phage therapy 
in feed, sanitation and bio-security measures. Of these aforementioned intervention 
strategies, this dissertation will be focused only on the use of vaccines and antimicrobials 
to reduce S. Ttyphimurium shedding in finisher swine. 
 
Vaccines to reduce Salmonella in swine  
Both innate and adaptive branches of the immune system play a role in host 
defenses against the bacterium Salmonella in swine.  Gastric pH, intestinal motility, host-
derived proteins such as defensins and proteolitic enzymes, normal intestinal microflora, 
non-specific host immune cells such as natural killer cells and γδ T cells are important 
innate host defenses against the infection.  As Salmonella has the ability to inhabit 
extracellular and intracellular niches of the host, antibody-mediated and cell-mediated 
responses of adaptive immune response are vital to control the infection (McSorley and 
Jenkins, 2000; Mittrucker et al., 2002; Tizard, 2004; Yrlid et al., 2001). The ideal vaccine 
against Salmonella should prevent colonization, shedding of the organism, the 
development of carrier stages and development of clinical disease, and promote 
elimination of the organism from the host (Haesebrouck et al., 2004). Live vaccines are 
considered to offer a better protection against Salmonella infection than the killed or 
inactivated vaccine. This superior protection could be related to better cell-mediated 
immune system elicited and induction of mucosal IgA antibody production by live 
vaccine strains (Hackett, 1990). Also, live vaccines are thought to provide protection 
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against both homologous and heterologous Salmonella infections (Chu et al., 2007; 
Matsui and Arai, 1992).  
Three types of live-attenuated vaccines have been tested experimentally. One 
vaccine type contains strains attenuated without targeting a specific gene or marker, for 
example temperature-sensitive mutants of Salmonella (Hooke et al., 1993).  Another 
vaccine type contains strains attenuated by mutating genes required for bacterial 
metabolism.  This category of vaccines includes auxotrophic strains generated by 
mutating genes such as galE (mutation in the gene required for GalE enzyme synthesis), 
purABEH (mutation in genes required for purine synthesis) and aroACD (mutation in 
genes required for aromatic amino acid synthesis), and strains carrying mutations in the 
regulatory genes such as cya (a gene required for the synthesis of adenylate cyclase), crp 
(a gene required for the synthesis of cAMP receptor protein) and pho (a global regulator 
gene) (Coe and Wood, 1992; Curtiss, III et al., 1989; Hoiseth and Stocker, 1981; 
McFarland and Stocker, 1987; Nnalue and Stocker, 1987). The third type of vaccine 
includes strains that carry mutations in the virulence genes such as inv genes located on a 
virulence plasmid of Salmonella (Kramer et al., 1992). Vaccine strains containing 
mutations in virulence genes are generally considered to be safer than the auxotrophic or 
temperature-sensitive mutants because they are unlikely to revert to the wild-type strain.  
In some auxotrophic vaccine strains, additional safety has been ensured by introducing a 
second mutation or curing virulence plasmids from the already attenuated strain (Chu et 
al., 2007).   
Because of the ubiquitous nature of Salmonella infection, and the use of 
Salmonella vaccines in control programs and Salmonella serology in control programs 
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recent attempts have been made to construct negative-marker vaccine strains so that 
antibodies produced against Salmonella can be distinguishable from those produced 
subsequent to infection (Selke et al., 2007). The ability to distinguish vaccinated form 
naturally infected animals would be advantageous because vaccination would not hinder 
current control programs dependent on serological tests.  
 
Antibacterial agents to reduce Salmonella in swine  
Antibacterial agents act on targets that are essential for bacterial survival and 
growth. These targets vary with the class of antibacterial agent and include bacterial cell 
wall biosynthesis (peptidoglycan), bacterial protein synthesis (ribosomes or enzymes 
involved in protein synthesis), bacterial DNA replication and repair, and bacterial cell 
membrane (Walsh, 2000). Antibiotics belongs to various groups of antibiotics are being 
used in swine for production enhancement as well as prophylactic for Salmonella. There 
has been various experimental challenge studies conducted to evaluate effectiveness of 
antibiotics to control Salmonella shedding in swine. Most of the studies had undergone 
microbial culture as to determine the presence or absence of Salmonella in feces while 
culture methods differ among studies.    
Although vast amount of literature describing detection and intervention strategies 
to control Salmonella in swine are available, no evidence-based approach has been 
carried out to analyze these data. Therefore, the objective of this dissertation is to 
summarize the available evidence for detection and control foodborne Salmonella in 
swine. In particular, the first objective of this thesis was to apply EBM approach to 
analyze studies of vaccine to control Salmonella in swine. Second objective was to 
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quantitative analysis of binary and continuous data of antibiotic studies to control 
Salmonella in swine using EBM approach. The third objective was to compare the 
sensitivity and specificity of in-house culture method to two PCR assays using Bayesian 
analysis in the absence of a gold standard test.   
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Table 1. The 20 most frequently reported Salmonella serotypes from human sources 
reported to CDC during the year 2005 
Rank Serotype 
1 Typhimurium 
2 Enteritidis 
3 Newport 
4 Heidelberg 
5 Javiana 
6 14,[5],12:i:- 
7 Montevideo 
8 Muenchen 
9 Saintpaul 
10 Braederup 
11 Ornienburg 
12 Mississippi 
13 Infantis 
14 Paratyphi B var. L(+) tartrate + 
15 Thompson 
16 Agona 
17 Typhi 
18 Hartfold 
19 Stanley 
20 Berta 
Source: http://www.cdc.gov/ncidod/dbmd/phlisdata/salmtab/2005/  
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Table 2. Non-clinical Salmonella isolates from porcine reported to CDC and National 
Veterinary Services Laboratories by serotype during the year 2005 
Serotype Non-clinical non-human source 
Derby 192 
Typhimurium 139 
Heidelberg 43 
Worthington 33 
Mbandka 25 
Agona 16 
14,[5], 12i:- 9 
Anatum 6 
Braenderup 4 
Johansburg 4 
Newport 4 
Lille 2 
Meleagridis 2 
Brandenburg 1 
Norwich 1 
Ohio 1 
Saintpaul 1 
Senftenberg 1 
Source: http://www.cdc.gov/ncidod/dbmd/phlisdata/salmtab/2005/  
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Table 3: Typical growth characteristics of Salmonella on some commonly used 
selective and differential media 
Media  Colony appearance 
Salmonella-Shigella agar Colorless colonies on a pink background 
Bismuth sulfite (BS) agar Black colonies surrounded by a brown to black  
zone that casts a metallic sheen 
Brilliant green (BG) agar Pink colonies surrounded by red zone 
Xylose lysine desoxycholate  
(XLD) 
Black-centered red colonies with H2S producers,  
red colonies with non-producers 
MacConkey (MA) agar Uncolored, transparent colonies 
Eosin-methylene Blue  
(EMB) agar 
Translucent amber to colorless colonies 
 Source: (Guthrie, 1992)   
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ABSTRACT 
 A systematic review was conducted to evaluate the efficacy of vaccination to 
reduce Salmonella prevalence in market weight finisher swine. A search of online 
databases, and selected conference proceedings was conducted to identify relevant 
studies. The review process followed relevance screening, methodological quality 
assessment and data extraction. Although multiple outcomes were frequently reported, 
only outcomes describing culture of Salmonella were extracted. Five clinical trials and 23 
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challenge studies were considered likely relevant to the review as they described 
vaccination to reduce Salmonella in swine. Five clinical trials reported vaccination was 
associated with reduced isolation of Salmonella in market weight pigs, however, 
information required to assess the internal validity of the study was often not described in 
the manuscripts. All challenge studies assessed vaccine efficacy in pigs aged less than 15 
weeks reducing the relevance of results to the review which focused on market weight 
pigs. Only five of the 23 challenge studies reported the majority of information necessary 
to evaluate the quality of vaccine studies. Given large variability in population type, 
sample size, type of vaccine, dose and dosing regimens, and type of outcomes observed, 
pooled data analysis was not possible, and therefore, a qualitative synthesis of the studies 
was conducted. Available evidence suggests that vaccination is associated with reduced 
Salmonella prevalence in swine at or near harvest; however, this conclusion is based on 
studies with design and reporting deficiencies that could potentially indicate biases with 
the outcome.  
 
INTRODUCTION 
SALMONELLA is considered one of the major foodborne pathogens transmitted by 
pork and pork products. Estimates of the proportion of  human cases of Salmonella 
attributable to pork vary from 5%  to 15% depending on the attribution approach used 
(Batz et al., 2005; Frenzen et al., 1999; Hald et al., 2004; Miller et al., 2005).  
Vaccination of pigs against Salmonella may be one means of reducing pre-harvest 
Salmonella prevalence and therefore, the number of swine carrying Salmonella into the 
slaughter plant.  Numerous studies reported vaccination to reduce Salmonella prevalence, 
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however, diffuse sources of data, multiple outcomes and the volume of work mean it is 
not readily apparent in what circumstances vaccination against Salmonella may be an 
effective means of pre-harvest control of Salmonella. The aim of this review was to 
appraise and synthesize studies describing vaccination as a method of reducing 
Salmonella prevalence in market weight finisher swine.  To synthesize these studies, a 
systematic review approach rather than a traditional narrative review was used (Cook et 
al., 1997; Mulrow, 1987; Sargeant et al., 2006b). 
Systematic reviews evaluate a topic using transparent, repeatable methods, and 
assess the internal and external validity of the primary research to the review question. 
The objective is to convey to the consumer of the review, not only the conclusion of the 
review, but sufficient information for the consumer to determine their agreement with the 
conclusion.  Inclusion of descriptive information about scope of the literature search, 
criteria used for inclusion of studies, and assessment of study quality informs the review 
consumer of potential biases and represents a major departure from traditional narrative 
reviews.   
 
MATERIALS AND METHODS  
To review the efficacy of vaccination against Salmonella and the association with 
Salmonella prevalence in swine, a stepwise procedure was followed. 
 
Question definition  
The study question was “In market weight finisher swine or sows in production 
systems of the European Union and developed nations of the Pacific Rim, what is the 
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association between Salmonella prevalence and vaccination against Salmonella”? 
Vaccination was defined as any intervention designed to stimulate a systemic immune 
response to protect against Salmonella.   Although many manuscripts reported multiple 
outcomes, only outcomes describing culture of Salmonella post-vaccination were 
considered for the review. The association of vaccination with antibody production or 
clinical disease occurrence was not considered for this review.  
 
Literature search and relevance screening   
A literature search was conducted of thirteen electronic online bibliographic 
databases, from their inception to April 2007. No language or publication restrictions 
were imposed for the searches. The databases selected as relevant to the review topic 
were  AGRICOLA (1970-2007), AGIRS (1975-2007), Biological and Agricultural Index 
(1983-2007), Biological Abstracts (1980-1989), Biosis Previews (1980-2007), CAB 
Abstracts (1973-2007), Current Contents (1998-2007), Dissertation Abstracts (ProQuest 
Digital Dissertations, 1961-2007), Food Science and Technology Abstracts (1969-2007), 
Ingenta Gateway (1997-2007), MEDLINE (1950-2007), PubMed (1965-2007), and Web 
of Science (1945-2007). Three major conference proceedings were searched by hand, 
starting at their inception:  American Association of Swine Veterinarians (1973-2007), 
International Pig Veterinary Society Congress (1969-2007), and International 
Symposium on the Epidemiology and Control of Salmonella in Pork (1996-2007). 
Reference lists of studies identified as relevant were checked for additional references. 
The search combined sets of terms related to swine; (1) population, (2) interventions, and 
(3) outcome. Search terms within each component were combined using “OR” and each 
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component was combined using “AND” (Population terms AND intervention terms AND 
outcome terms). The population terms used in the original search were hogs, hog, swine, 
pig, pigs, gilts, sows, market-weight, finishers, boars and porcine.  The original search 
was designed to capture studies describing various pre-harvest  interventions associated 
with Salmonella reduction in swine, but the specific terms used to identify vaccine 
studies were vaccines, vaccination, immunization, intervention and management practice. 
The outcome terms included were carcass swabs, culture, serology, prevalence, 
incidence, risk factors, cecal lymph nodes, pharyngeal swabs, feces, fecal contents, rectal 
swab, rectal contents, mesenteric lymph nodes and salmonell*.   
Reference management (Reference Manager 11, Thomson ResearchSoft, USA) 
and electronic systematic review software (Systematic Reviews SRS 3.0, TrialStat 
Corporation, Canada) were used to coordinate the review process. For each citation 
identified, abstracts were uploaded into the reference management program. After 
removing duplicates, citations were uploaded into the electronic systematic review 
software, and screening for relevance to the review question was conducted. All four 
reviewers initially read the same fifty abstracts, and the results were discussed to reach 
agreement about which papers should be included.  Inclusion criteria for relevance 
screening were 1) primary research in English, 2) Ph.D. theses in English,  3) citations 
from conference proceedings 4) described evaluation of vaccination against Salmonella 
in swine in a challenge trial or clinical trial, and 5) reported ante-mortem or post mortem 
presence of Salmonella in swine. Exclusion criteria included 1) primary research in 
languages other than English, 2) Ph.D. theses in languages other than English, 3) 
literature reviews, and 4) other articles, such as letters, comments, and editorials. The 
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abstracts were assigned to reviewers in blocks, because random assignment was not 
possible using the commercial software.  Two reviewers read each abstract 
independently, and excluded references not meeting the inclusion criteria. During 
relevance screening, the reviewers were blinded to the source of each reference, but the 
author was known.  In cases where the two reviewers disagreed, discussions were held to 
resolve the disagreement.  
 
 Assessment of the methodological soundness of the relevant studies  
Using full articles, the methodological soundness and completeness of all relevant 
studies was independently assessed by two reviewers using checklists to assess challenge 
trials and clinical trials. The checklists had been created by agreement of the authors. The 
assessment specifically evaluated the materials and methods section of the manuscripts 
for complete descriptions of the vaccination, challenge, and outcome measurement 
protocols. A complete description of the vaccination protocol included vaccine organism 
(S. choleraesuis or S. typhimurium, or subunit), route of administration, frequency of 
administration and dose. A complete description of the challenge included identification 
of the organism used (S. choleraesuis or S. typhimurium), dose, route and timing of 
administration relative to vaccination. Age of pigs at vaccination or challenge with 
Salmonella was not considered as part of the quality assessment. A complete description 
of the outcome included the timing of sample collection after vaccination and challenge, 
the type of sample (fecal or tissue), size of sample, and the culture method. A “low” 
grade was assigned to a manuscript if both reviewers agreed that either randomization 
was not explicitly stated or that vaccination protocol, challenge protocol, outcome 
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assessment or statistical analysis was not described fully. A “high” grade was assigned 
when both reviewers agreed that these criteria were satisfactorily met. As few studies 
reported blinding, this factor was excluded from the methodology assessment and 
reported separately. Prior to starting the assessment, 5 articles were reviewed by all 
reviewers and agreement was assessed.  Thereafter, two reviewers independently 
assessed each article. Disagreements between reviewers were resolved by consensus. The 
checklists for the methodology assessment are available from the first author.  
 
 Data extraction and summarization 
 A standardized form was used to extract information from each manuscript for 
the most externally valid studies only (Sargeant et al., 2006a). The assessment of external 
validity was based on the measurement of Salmonella in market weight swine. One 
reviewer (TD) was responsible for extraction of primary data. Data extraction included 
the characteristics of population, intervention and level of allocation to treatment groups, 
outcome, and results. Only outcomes describing ante-mortem or post-mortem culture of 
Salmonella post-vaccination were extracted.  
 For data extraction we aimed to extract and report the most informative data 
available that conveyed the study result, therefore we tried to extract raw data with 
prevalence of Salmonella in the vaccinated and unvaccinated group and to report the p 
value associated with these data.  If raw data information were not reported, we extracted 
summary data such as proportions, percentages, relative risk or vaccine efficacy with 
confidence intervals or p values, if available.  If these data were not available we tried to 
report the results of hypothesis testing with preference given to reporting the exact p 
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value. If the exact p value was not reported ,we would extract information that indicated 
the result of significance testing either as p <0.05 and finally, only if no other information 
was available we reported that the association was significant or not significant if that 
was all that was provided.   
 
RESULTS  
Studies identified, relevance screening, quality assessment, and data extraction   
20,814 references were identified, 20,655 references identified in the 13 
bibliographic electronic data bases and 159 references in the three major conference 
proceedings. After duplicate removal, 8,087 unique references were identified for 
relevance screening.  Based on the title and the abstract, 7,807 references did not meet the 
inclusion criteria. Of the 280 abstracts that passed initial relevance screening based only 
on the abstract, 254 were deemed not relevant based on evaluation of the full article, 
leaving 27 articles that reported vaccination against Salmonella in swine. One article 
described two trials, a challenge trial and a clinical trial, therefore, 28 unique studies were 
considered for the review. Table 1 describes the methodology grade received, 
randomization and blinding for the 28 studies that discussed vaccination against 
Salmonella. Only 5 of the 28 articles received a high methodological quality score.    
 
Characteristics of the studies 
From the manuscripts identified, 5 clinical trials and 23 challenge studies were 
reported.  Twenty two studies were conducted in North America; 20 and two in the USA 
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and Canada, respectively. Five studies were conducted in Europe; three studies in 
Germany, and one each in the United Kingdom and Ireland. The other study was carried 
out in Brazil. Studies were published between 1979 and 2006, and the sample size ranged 
from 8 to 7,000 pigs. Not all the studies tested for Salmonella status prior to the 
intervention. Table 2 and Table 3 summarize the characteristics of challenge studies and 
clinical trials, respectively, and describe the type of pig studied, the setting, age at 
vaccination and age at outcome assessment. None of the challenge studies were 
conducted using market weight finisher swine. The outcome of the five clinical trials was 
assessed in market weight finisher swine, and therefore, data were extracted from only 
these trials. 
 
Evidence for an association between vaccination and Salmonella status in pigs   
Vaccination protocols and outcomes from the five clinical trials reporting 
recovery of Salmonella in market weight finisher pigs are reported in Table 3. The 
outcomes measured differed for each study, however, each trial reported vaccination was 
associated with reduced Salmonella prevalence. We were unable to extract and report raw 
data from any of the five trials. Summary data were reported for one trial, which 
suggested that vaccination with a live modified S. choleraesuis vaccine twice at 3 and 16 
weeks of age was effective in reducing Salmonella prevalence in ileocecal lymph nodes 
at slaughter (Maes et al., 2001).  The prevalence of Salmonella in the unvaccinated barns 
was 7.2% compared to 0.6% in vaccinated barns (Relative risk: 0.083, 95% confidence 
interval 0.019 - 0.35) (Maes et al., 2001). The remaining four clinical trials also reported 
Salmonella prevalence was reduced in vaccinated animals, however, it is not possible to 
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report the magnitude of Salmonella reduction as these four trials reported only p-values 
or the number of Salmonella positive animals without indicating how many animals were 
in the study group. (Maes et al., 2001)found that following use of a commercially 
available S. choleraesuis live vaccine, only 0.6% and 7.2% of the ileocecal lymph nodes 
were positive for Salmonella in the vaccinated and control group, respectively, at 
slaughter (p<0.001). Whereas, (Baum et al., 1997) observed a significant difference in the 
culture prevalence of S. typhimurium serogroups B and C1, but not serogroups C2 and E 
in response to vaccination. Further, the authors reported that the total significance 
difference of Salmonella recovery from vaccinated and nonvaccinated groups was 
p<0.05. In a trial carried out by (Kolb et al., 2002), vaccinated pigs showed significant 
reduction in percentage of carcasses culture positive for Salmonella culture at slaughter 
(p=0.02). The authors also reported a reduction in Salmonella prevalence in spiral colon 
fecal samples (p=0.1) as a result of vaccination. In a study conducted by (Roesler et al., 
2006) using a homologous inactivated herd-specific Salmonella vaccine in sows, S. 
typhimurium could not be detected in fecal samples from the piglets of vaccinated sows, 
and subsequently, in gilts. Also, a large trial carried out by (Schwarz et al., 2007)6 
reported that following use of a commercially available S. choleraesuis vaccine, 
significant reduction in the rate of Salmonella isolation from mesenteric lymph nodes 
(p<0.05).   
All five clinical trials received a low methodology quality score (Table 1). 
Common features of the studies were failure to report a statistical method that would 
account for clustering and failure to report blinding. One study reported randomization at 
the group level (n=12, 6 vaccinated groups and 6 control groups), but did not report 
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blinding at outcome assessment or withdrawals from the study (Maes et al., 2001).  The 
prevalence of Salmonella in the unvaccinated barns was 7.2% compared to 0.6% in 
vaccinated barns (Relative risk: 0.083, 95% confidence interval 0.019 - 0.35). Another 
study reported random allocation of 8 buildings (4 vaccinated, 4 control) to treatment 
groups however it was not possible to fully assess if clustering had been accounted for as 
the descriptions of statistical methods were short (Baum et al., 1997). Although the 
number of Salmonella positive animals was described, the number of animals tested was 
not clear, therefore, primary data could not reliably be extracted.  The other three clinical 
trials (Kolb et al., 2002; Roesler et al., 2006; Schwarz et al., 2007) failed to provide 
enough data for re-analysis or assessment of the controlling for biases (Table 3). 
Therefore, consistent with systematic review methodologies, these studies provided little 
strong evidence to support the efficacy of vaccine against Salmonella in market weight 
finisher swine.  
Five challenge studies received a high methodology score; however, Salmonella 
status was not assessed in market age swine. The remaining studies were not used as 
evidence of an association, because they had a low methodology score and Salmonella 
status was not assessed in market age swine. The majority of these studies reported a 
positive association of vaccination with Salmonella culture measured either in feces or 
tissue samples.   
 
DISCUSSION 
The association between vaccination and Salmonella reduction in market weight 
finisher swine is promising but not definitive. Unfortunately, none of these studies 
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contributed high quality evidence supporting the use of vaccination to reduce Salmonella 
in market weight finisher swine because of failures to report key components of the study 
necessary to assess the evidentiary value of the research.  If the evidentiary value and 
disparity in outcome measures are ignored, all five clinical trials suggest that vaccination 
is associated with reduction in Salmonella (Table 3).  Our conclusion is that current 
evidence suggests some vaccines are effective, however, because of the methodological 
quality of the studies identified for this review; it is possible that this conclusion is 
incorrect. Another limitation to this conclusion is analysis based on binomial outcome. 
Enumeration data of the effect of vaccination on Salmonella microbial load reflect the 
risk better than the prevalence. Therefore, if enumeration data were available in 
manuscripts, may capture different and potentially more relevant effects as microbial 
load, as well as prevalence, are likely associated with the human health risk. 
Unfortunately, none of the manuscripts identified reported enumeration data.  
Systematic reviews assess two features of studies, external validity and internal 
validity. External validity refers to the applicability of the study to the review question 
and depends upon the population studied and the outcome reported.  The internal validity 
refers to accurate measurement of the outcome in the study population apart from random 
error.  Biases that prevent internal validity include selection bias, misclassification bias 
and confounding bias. In studies of interventions, randomization and blinding limit the 
impact of confounding and misclassification bias, respectively.  The best evidentiary 
value for an intervention such as vaccination comes from randomized clinical trials with 
high external and internal validity i.e. provide a high level of evidentiary value (Persaud 
and Mamdani, 2006). In this review, we identified five clinical trials with high external 
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validity, based on the population and outcomes reported. However, our rationale for 
tempering our review conclusion is based on internal validity. Four of the five clinical 
trials reported randomization at the group/building level in the study population of 
interest. However, these studies failed to report analyses that would account for 
clustering, and therefore, introduced the possibility of bias. Failure to account for 
clustering increases chance of rejecting the null hypothesis when it is true. This problem 
is addressed by (Cornfield, 1978); “randomization by cluster accompanied by an analysis 
appropriate to randomization by individual is an exercise in self-deception and should be 
discouraged”.  
Similarly, blinding is an essential feature associated with internal validity to limit 
the introduction of differential misclassification bias (Montori et al., 2002). Without a 
formal description of a blinding protocol, it is not possible to assess the extent to which 
this bias has influenced the study outcome. It could be argued that Salmonella culture is a 
blinded outcome, however, for barn level studies it is possible that awareness of the 
vaccination status of the barn being cultured could lead to increased scrutiny of cultures 
or re-run doubtful results, and therefore, different sensitivity and specificity for culture 
results for vaccinated and unvaccinated barns. We acknowledge it is also possible that 
studies used but failed to report formal randomization and blinding, and if this is the case, 
our assessment of the literature may be overly conservative (Callaham et al., 1998).  
Veterinary vaccine challenge studies should provide evidence for vaccine 
efficacy, because researchers are able to control internal biases and have fewer barriers to 
studying the animal population of interest. All challenge studies, however, lack some 
external validity due to the inability to replicate field conditions such as concurrent 
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disease/organism exposure, which may be important in disease ecology (Table 2). The 
challenge for the reviewer is to balance the information from a challenge study with the 
relevance of the field environment. In selecting which studies to extract data and report, 
we chose only the most relevant based on our assessment that differences in immune 
system of young and mature pigs and the absence of concurrent disease challenge were 
sufficient, for us, to conclude these studies were not applicable to the review question 
(Baum et al., 1997; Charles et al., 1999; Charles et al., 2000a; Charles et al., 2000b; Coe 
et al., 1992; Draayer, 1986; Foster et al., 2003; Gibson et al., 1999; Groninga et al., 2000; 
Hanna et al., 1979; Husa et al., 2006; Kennedy et al., 1999; Kern, 1994; Kolb et al., 2001; 
Kramer et al., 1987; Kramer et al., 1992; Ku et al., 2005; Letellier et al., 2000; Lumsden 
et al., 1991; Neubauer and Roof, 2005; Roesler et al., 2004; Roof and Doitchinoff, 1995; 
Springer et al., 2001). This assessment of relevance is subjective and review consumers 
may disagree, however, communication of the value of information was considered for 
the review as part of the systematic review process. Likely, similar judgments are made 
by traditional reviews although the process may not be as apparent. Further, it is 
important to note that a lack of external validity was a consequence of our review 
question.  Many studies had the primary function to assess clinical disease associated 
with S. choleraesuis and fecal recovery of Salmonella was a secondary outcome, a 
different review question would reach different conclusion about the external validly of 
the study.  Unfortunately, many of the challenge studies also failed to control for internal 
biases with blinding and randomization.  
An ancillary finding in the review was the large amount of detail often excluded 
from study reports. Only 5 of 28 studies provided a complete description of the 
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vaccination, challenge and outcome protocol, suggesting a common problem with 
reporting and manuscript preparation that likely limits the usefulness and reproducibility 
of these studies. “Low” methodology scores were often, but not always, associated with 
conference proceedings, for example, three of the clinical trails reported were identified 
in conference proceedings  and contained little detail of the study protocols (Baum et al., 
1997; Kolb et al., 2002; Schwarz et al., 2007).  Obviously, the limitations on space in 
conference proceedings prevent authors from including critical information. Another 
consideration should be that published reports suggest conference proceedings tend to 
present more favorable results than subsequent peer-reviewer publications of the same 
material (Callaham et al., 1998; Hopewell et al., 2006).   
We did not report a meta-analysis as part of the systematic review. Meta analysis 
is the quantitative method use to make pooled estimate of effect measure of individual 
studies. Systematic reviews may or may not include a meta-analysis. It is important to 
recognize the distinction between systematic review and meta-analysis, because it is 
always appropriate and desirable to systematically review a body of data, but it may be 
inappropriate or even misleading, to statistically combine results from independent 
studies (Egger et al., 2001). As reported, most studies provided little detail about the 
studies; therefore, we could not assess if the population type, sample size, type of 
vaccine, dose and dosing regimens, and type of outcomes observed were sufficiently 
similar among all five clinical trials, to warrant calculation of a combining effect 
measures (Moher et al., 2001; Naylor, 1995). Further, even if we were assured it was 
sensible to estimate a single effect or distribution of effect, only one of five studies 
reported the data needed for a meta-analysis.  As meta-analysis works best when studies 
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have homogeneous settings, designs and quality, and outcome measures with small 
sample sizes, therefore, data from one study is insufficient for a meta-analysis (Moher et 
al., 2001; Naylor, 1995).   
 
CONCLUSION 
 The evidence available suggests that Salmonella vaccines are associated with 
reduced Salmonella prevalence in swine at or near harvest. However, this conclusion is 
based on studies with design and manuscript deficiencies that could potentially indicate 
biases such as confounding, allocation and assessment bias associated with the outcome 
but not the result of vaccination.  
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TABLE 1.  Randomization, Blinding and Methodological Quality Grade of 28 Studies 
Reporting Vaccination of Swine Against Salmonella Associated with Foodborne 
Outcomes 
Author Randomization Blinding at 
outcome 
assessment 
Overall 
methodology  
assessment 
Clinicaltrials      
Baum et al., 1997  Barn level allocation with 8 barns 
of 1100 head: 4 vaccinated barns, 
4 nonvaccinated barns 
Not reported Low 
Kolb et al., 2002 Barn level allocation with 12 
vaccinated barns and 12 
nonvaccinated barns. The group 
size was not described.  
Not reported Low 
Maes et al., 2001 Barn level allocation with 12 
groups of 380 pigs: 6 vaccinated 
barns and 6 nonvaccinated barns 
Not reported Low 
Roesler et al., 2006 Not reported Not reported Low 
Schwarz et al., 2006 Barn level allocation of 3,500 pigs 
to both treatment and control 
groups: number of barns not 
described 
Not reported Low 
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Challenge studies       
Charles et al., 2000a Individual random allocation Not reported High 
Husa et al., 2006 Individual random allocation to 
groups, and blocked by weight 
and sex 
Adequate High 
Letellier et al., 2000 Individual random allocation to 
groups 
Not reported High 
Lumsden et al., 1991 Blocked by litter and randomized 
with block 
Adequate High 
Neubauer et al., 2005 Reported without description Adequate High 
Baum et al., 1997  Reported without description Not reported Low 
Charles et al., 1999 Reported without description Not reported Low 
Charles et al., 2000b Reported without description Not reported Low 
Coe et al., 1992 Not reported Adequate Low 
Draayer 1986 Not reported Not reported Low 
Foster et al., 2003 Not reported Not reported Low 
Gibson et al., 1999 Blocked by sex and weight  Not reported Low 
Groninga et al., 2000 Reported without description Not reported Low 
Hanna et al., 1979 Not reported Not reported Low 
Kennedy et al., 1999 Blocked by weight and 
randomized with blocks 
Adequate Low 
Kern et al., 1994 Reported without description Not reported Low 
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Kolb et al., 2003 Blocked by sex and weight Not reported Low 
Kramer et al., 1987 Blocked by sex and weight Not reported Low 
Kramer et al., 1992 Individual random allocation to 
groups 
Double 
blinded 
Low 
Roesler et al., 2004 Not reported Adequate Low 
Roof et al., 1995 Individual random allocation to 
groups 
Not reported Low 
Springer et al., 2001 Not reported Not reported Low 
Ku et al., 2005 Not reported Not reported Low 
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TABLE 2.  THE COUNTRY, ANIMAL TYPE AND AGE OF ANIMALS IN THE CHALLENGE 
STUDIES REPORTING VACCINATION OF SWINE AGAINST SALMONELLA ASSOCIATED WITH 
FOODBORNE OUTCOMES 
 
Author Country Type of pig Age at enrollment  
Baum et al., 1997 USA Commercial  3 weeks 
Charles et al., 1999 USA Commercial  3-4 weeks 
Groninga et al., 2000 USA Commercial 3 weeks 
Kolb et al., 2003 USA Commercial 2 weeks 
Kramer et al., 1992 USA Commercial Nursery pigs 
Kramer et al., 1987 USA Commercial Weaned 
Neubauer et al., 2005 USA Commercial 3 weeks 
Roof et al., 1995 USA Commercial 3-4 week  
Charles et al., 2000a USA Experimental 3-4 weeks 
Charles et al., 2000b USA Experimental 3-4 weeks 
Kennedy et al., 1999 USA Experimental 7 weeks 
Ku et al., 2005 USA Experimental 5-8 weeks 
Springer et al., 2001 Germany Experimental 3-4 week 
Coe et al., 1992 USA SPF 8 weeks 
Hanna et al., 1979 Ireland SPF 7 weeks 
Lumsden et al., 1991 Canada SPF 5-6 weeks 
Roesler et al., 2004 Germany SPF 4 weeks 
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Foster et al., 2003 UK Gnotobiotic 5 days 
Draayer 1986 USA Not defined 5 weeks 
Gibson et al., 1999 USA Not defined 3-4 weeks 
Husa et al., 2006 USA Not defined 3 weeks 
Kern et al., 1994 USA Not defined 3-4 weeks 
Letellier et al., 2000 Canada Not defined 12 days 
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CHAPTER 4  
A REVIEW OF ANTIBIOTICS TO REDUCE SALMONELLA IN SWINE: 
QUANTITATIVE ANALYSIS OF BINOMIAL AND CONTINUOUS DATA 
A paper to be submitted to Zoonoses and Public Health  
 
T. N. Denagamage  
 
Summary  
The administration of sub-therapeutic levels of antibiotic as a prophylactic in 
swine feed is commonly practiced in swine production systems. To summarize the 
efficacy of antibiotic use in feed to control Salmonella Typhimurium shedding in swine, a 
systematic review of the literature and a meta-analysis were conducted. Multiple online 
data bases were searched through May 2007 with combination of search terms 
describing; population, intervention and outcome of interest for the review. Two 
reviewers independently applied selection criteria, carried out quality assessment, and 
one reviewer extracted the data. Fourteen challenge trials described the efficacy of 
different group of antibiotics in swine after challenged with S. Typhimurium. The most 
widely used group of antibiotic was tetracycline group either alone or combined with 
neomycin next to bambermycin group. Both binary and continuous outcome were 
assessed for variation between multiple time points within studies, and between studies. 
Continuous data were analyzed using standardized mean differences and 95% confidence 
intervals while relative risks and 95% confidence intervals were calculated for binary 
data. The analysis of statistical heterogeneity between multiple time points in studies 
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suggest no statistical heterogeneity between multiple time points of individual studies for 
binary and continuous outcome. However, the assessment of heterogeneity between 
studies evaluating the same group of antibiotic showed statistically significant evidence 
of heterogeneity in tetracycline group of studies and studies of tetracycline with 
neomycin. There was no statistical heterogeneity between two studies of bambermycin, 
and summary Mantel-Haenszel risk ratio and 95% confidence interval (0.80, 0.65 - 0.98) 
was calculated. Limitations of these findings were that these studies were challenge 
studies, and outcome was measured before the age of market weight. Therefore, length of 
follow-up has been too short to assess the efficacy of antibiotics in market weight swine.   
 
Introduction 
Salmonella Typhimurium is a foodborne pathogen commonly associated with 
consumption of pork however infection with S. typhimurium in swine generally leads to 
asymptomatic carrier state, although the animals may shed the organism in feces 
(Schwartz, 1991; Wilcock and Olander, 1978).  As part of a larger project to evaluate the 
effectiveness of numerous interventions to reduce Salmonella in swine (O'Connor et al., 
2006), we reviewed the literature describing the association between sub-therapeutic 
level of antibiotics use in swine feed and S. Typhimurium shedding. Shedding was 
evaluated using binary and continuous measures of Salmonella.   
Antimicrobial agents have been used in swine feed supplements for many years to 
control Salmonella Choleraesuis infections. S. Choleraesuis is a host adapted pathogen 
that is associated with paratyphoid in swine (Schwartz, 1991). Growing interest in food 
safety has promoted several researchers to evaluate the efficacy of sub-therapeutic levels 
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of antibiotic in feed or water to reduce the presence of S. Typhimurium shedding or 
duration of Salmonella shedding in swine. However, no attempts have been made to 
summarize the efficacy of sub therapeutic level of antibiotics used to reduce Salmonella 
in swine across numerous studies. The magnitude of the expected impact of sub 
therapeutic levels of antibiotic on S. Typhimurium summarizing the efficacy across 
several studies should provide a better estimate of the overall expected effect. Therefore, 
this systematic review and meta-analysis is an attempt to summarize the efficacy of 
antibiotics from published studies.  
 
Materials and methods 
The objective of the systematic review and meta-analysis was to summarize the 
efficacy of the intervention of interest,  sub-therapeutic antibiotics in feed or water , to  
reduce S. Typhimurium shedding in the population of interest i.e. finisher swine in 
modern swine production systems and compare the inference obtained from studies 
reporting continuous and categorical outcomes.  Only field trials and challenge trials 
conducted to evaluate the efficacy of sub-therapeutic antibiotics were considered relevant 
for the review. The outcome of interest was the presence of S. Typhimurium in swine 
feces measured by culture and reported as either a binary variable (presence or absence of 
S. Typhimurium) or a continuous variable (number of colony forming units). Evidence of 
prior exposure to Salmonella measured by serological methods was not considered 
relevant to the review and these studies were excluded.   
The 1st step in the review was to indentify studies relevant to the review topic; 
therefore, an extensive literature search was performed using online electronic data bases 
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from inception to May 15th, 2007. The databases were AGRICOLA (1970-2007), AGIRS 
(1975-2007), Biological and Agricultural Index (1983-2007), Biological Abstracts (1980-
1989), Biosis Previews (1980-2007), CAB Abstracts (1973-2007), Current Contents 
(1998-2007), Dissertation Abstracts (ProQuest Digital Dissertations, 1961-2007), Food 
Science and Technology Abstracts (1969-2007), Ingenta Gateway (1997-2007), 
MEDLINE (1950-2007), PubMed (1965-2007), and Web of Science (1945-2007). To 
capture the relevant studies, search strings were designed to capture the population of 
interest, the intervention of interest and outcome of interest. Search terms within a group 
were combined with “OR”, and group of terms were combined with “AND”. The terms 
used to capture the population were: boar or porcine or gilt or sow or market-weight or 
finisher or pig or swine or hog. The terms used to capture the intervention used were 
additive or forage and feed science or antibiotic or ionophore or natural additive or feed 
concentrate or medicated feed or food microbiology or lactic acid bacteria or organic acid 
and salts or dietary mineral supplements or ergogenic acids or feed supplements or 
protein supplement or vitamin supplement or vitamin-mineral supplement or water 
acidifiers or water treatment or probiotic* or prebiotic*. Finally the terms used to capture 
the outcome were carcass swab or cecal lymph node or pharyngeal swab or feces or fecal 
content or rectal swab or rectal content or mesenteric lymph node or cecal content or 
fecal shedding or fecal shedding. The term salmonell* was included at the end of each 
string with “AND”. Language restrictions were not imposed for the literature search. To 
augment to electronic search, hand searching for relevant studies was also conducted of 
important conference proceedings: American Association of Swine Veterinarians (1973-
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2007), International Pig Veterinary Society Congress (1969-2007), and International 
Symposium on the Epidemiology and Control of Salmonella in Pork (1996-2007). 
After identification the potentially relevant citations were retrieved, and each 
citation was assessed by two reviewers. The screening questions were; 
(1) Does the abstract describe primary research in English? 
(2) Does the abstract describe the use of orally administered product in swine? 
(3) Does the abstract report ante-mortem or post-mortem presence of Salmonella in pigs? 
The above screening questionnaire selected studies describing antibiotics use in 
swine, and acidification of feed or water in swine. This review will focus only on 
antibiotic use to reduce Salmonella in swine. Electronic systematic review software 
(Systematic Reviews SRS 3.0, TrialStat Corporation, Canada) was used to coordinate the 
review process.  Disagreements between reviewers about the review questions were 
resolved by discussion during the relevant screening.  
 After identifying citations likely to be relevant to the review topic, full texts of 
potentially relevant citations were retrieved. The methodological qualities of the full 
manuscripts were again independently assessed by two reviewers. The checklist of 
quality assessment ensured the minimum quality required to evaluate the design and 
conduct of challenge trials and field trials. Studies that did not report the specific quality 
items within the checklist were excluded from the review.  
Criteria applied for the quality assessment checklist of challenge studies were; 
(1) Were sampling units randomly assigned to the treatment groups?  
(2) Were the intervention protocols adequately described? 
(3) Was an appropriate control group used?  
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(4) Were the methods used to measure the outcome standard adequately described? 
(5) Was the type of statistical analysis appropriate for the study design?  
Criteria applied for the quality assessment checklist of field trials were; 
(1) Were the animals housed or grouped in a way that is representative of field 
conditions? 
(2) Were sampling units randomly assigned to the treatment groups?  
(3) Was an appropriate control group used?  
(3) Were the intervention protocols adequately described?  
(4) Was the type of statistical analysis appropriate for the study design? 
 From each study that met the quality assessment criteria, binominal and 
continuous data describing Salmonella outcome were extracted from treatment and 
control group from multiple time points where the outcome were measured. When more 
than one antibiotic regimen was evaluated within a study, data from sub-therapeutic 
antibiotic treatment group compared with the control group was considered relevant for 
the review. For studies that reported Salmonella recovery on multiple days after 
challenge with Salmonella, data from each day was extracted. Binominal data extracted 
were number of animals per group, number of animals’ positive and negative for 
Salmonella. For continuous data, either Salmonella counts in number of colony forming 
units per gram (cfu/g) of feces or mean number of cfu/g of feces or log mean number of 
cfu/g of feces or geometric mean number of cfu/g of feces isolated in each treated 
antibiotic and control groups were extracted. When only continuous data were reported 
these were also transformed into binary data. When data were only presented graphically, 
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the values were estimated by measurement from the graph. Data were extracted by one 
reviewer (TD) onto a data extraction form (Sargeant et al., 2006).  
To assess the overall association between sub-therapeutic antibiotic use and 
Salmonella recovery in swine, a meta-analysis approach was used using separate analysis 
for binary and continuous data for each antibiotic family. For binary data, if the number 
of animals positive for Salmonella in both treatment and control group was zero for any 
given day within a study, that particular day was excluded from the analysis. If the 
number of animals positive was zero in either treatment or control group (i.e. only one 
cell of the 2 by 2 table), then 0.5 was added to each cell of the 2 x 2 table for that 
particular day (Egger et al., 2001).  
If the continuous data were presented in the form of number of cfu for each 
individual animal, the mean log cfu for the group was calculated using the formula;  
10log XY
n
=  
Where Y is the mean of the log cfu in either antibiotic treated or control group for 
a given time point. X is the number of cfu in either antibiotic treated or control group for 
a given day and n is the number of animals in either antibiotic treated or control group. 
When the group level variable “mean number of cfu” was reported this outcome 
was transformed into the log mean cfu using the formula: 
Y = log10 X 
Where Y is the log mean number of cfu for either antibiotic treated or control 
group, and X is the mean number of cfu either antibiotic treated or control group.   
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When the geometric mean number of cfu per gram of feces per group was 
presented this was transformed into mean of the log cfu for the analysis using the 
formula: 
Y = log10 Z 
Where Y is mean of the log cfu per gram of feces, and Z is the geometric mean 
number of cfu per gram of feces in either antibiotic treated or control group for a given 
day (Geometric means is the average of the logarithmic values of a data set, converted 
back to a base 10 number).  
The statistical analyses were performed by Stata 8.2 (Statacorp, TX), SAS 
9.1(SAS Institute Inc., Cary, NC), and Comprehensive Meta-Analysis 2.0 (Biostat, 
Englewood, NJ).     
The statistical analysis required a step wise approach. The 1st step assessed the 
heterogeneity of the outcome within a study i.e. heterogeneity between multiple time 
points in individual studies. Statistical heterogeneity of effects measured relative risk 
(RR) across multiple time points in studies was assessed by the Cochran's Q statistic. 
Cochran's Q test was used to test the null hypothesis that the effect at multiple time points 
is equal for a binary outcome (RR). The null hypothesis was that the RR for multiple time 
points was not homogeneous. The p value for Cochran's Q statistic less than 0.1 was 
considered evidence against the null hypothesis. If there was no reason to reject the null 
hypothesis investigating the homogeneity for multiple time points in studies, the next 
analysis step was to combine days across a study to calculate a summary effect measure 
of the difference between the treatment and control groups for each study. The summary 
effects measure for binary data was expressed as study-specific Mantel-Haenszel risk 
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ratio (θ MH-study ) with 95% confidence interval. If the summary θ MH- study was less than 
one and 95% confidence interval did not include one, the interpretation was that the 
particular antibiotic was associated with reduced shedding of S. Typhimurium. When the 
confidence interval for θ MH-study included the null value of one, the interpretation was no 
evidence in efficacy between treatment and control group.  If the summary θ MH- study  was 
greater than one and 95% confidence interval did not include one, the interpretation was 
that the particular antibiotic was associated with increased shedding of S. Typhimurium. 
For continuous data, statistical heterogeneity of effects measured standardized 
mean difference (SMD) across multiple time points in studies and assessed by the 
Cochran's Q statistic. Cochran's Q test was used to test the null hypothesis that the SMD 
for multiple time points was homogeneous.  The p value for Cochran's Q statistic less 
than 0.05 was considered evidence against the null hypothesis. If not evidence was found 
to reject the null hypothesis when investigating the homogeneity for multiple time points 
in studies, the next analysis  step was to combine the multiple time points with a study to 
calculate a summary effect measure (SMD) of the difference between the treatment and 
control groups for each study. The summary effect measure for continuous data was 
expressed as study-specific standardized mean difference (SMDstudy) with 95% 
confidence interval. If the summary SMDstudy  was greater than zero and 95% confidence 
interval did not include zero, the interpretation was that the particular antibiotic was 
associated with reduced shedding of S. Typhimurium in the antibiotic treated group.  If 
the summary SMDstudy  was less than zero and 95% confidence interval did not include 
zero, the interpretation was that the particular antibiotic was associated with increased 
shedding of S. Typhimurium in the antibiotic treated group.   
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After analysis of the individual study outcomes, the aim of the next analyses was 
to evaluate if studies reporting the use of the same antibiotic reported similar outcomes. 
Cochrane Q test statistic was calculated as above for multiple studies of same group of 
antibiotics using binary and continuous data. Finally if the analysis suggested the 
outcomes across the studies with the antibiotic group were homogeneous, a summary 
effect measure was calculated for the antibiotic group (θ MH antibiotic,  SMD antibiotic). The 
formulae for Q statistics and summary effect measures are below.  
Step 1: Heterogeneity between multiple time points in individual studies 
To assess the heterogeneity between outcomes measured in multiple time points 
within each study for binary data, Cochrane Q statistic was calculated in STATA using 
metan command.  
Q statistic is given by 
( )i i MHQ w θ θ= −∑ 2 
Where θ  is the log relative risk 
When the P > 0.05 for the Q statistic, we assumed that evidence against the null 
hypothesis, and therefore fixed effect model was used to calculate the summary relative 
risk. This approach treated days within a study as independent based on the Q statistics.    
Heterogeneity between multiple time points in each study for the continuous 
outcome was assessed using Cochrane Q statistic given by 
( )i i IVQ w θ θ= −∑ 2 
where θ  is the standardized mean difference  
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where  θ  is the standardized mean difference (SMD) for time point i 
θ  = 
MeanDifference
PooledSD
 
The weight applied was inverse variance in fixed effect model.   
weight is given by  
 
Standard error of IVθ is given by 
1( )IV
i
SE
w
θ =
∑
 
Values for Q statistic with a P value < 0.05 were considered as evidence of 
heterogeneity. When there was no evidence of heterogeneity between multiple time 
points in individual studies, it was decided that it is appropriate to combine the data 
within studies. 
Step 2: The summary effect measure for binary data was given by the Mantel-Haenszel 
risk ratio (θ MHs ) given by 
i i
MH
i
w
w
θ
θ =
∑
∑
 
where  θ  is the risk ratio for time point i 
weight is given by   
iw  = 
i i
i
c n
N
 
and ic  is the number of events occurred in the control group for time point i 
2
1
( )i i
w
SE θ
=
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and in  is the number of individuals in the vaccinated group for time point i 
and iN  is the number of individuals in the study for time point i 
 The summary effect measure for continuous data was given by summary 
standardized mean difference calculated for each study using mean difference and 
standard deviation in multiple days using metan command in STATA. 
  
i i
IV
i
w
w
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∑
 
 
 
 
where θ  is the standardized mean difference (SMD) for time point i 
Step 3) Heterogeneity between same groups of antibiotic studies  
Heterogeneity between studies of same antibiotic family was assessed using 
binary and continuous data where available. Each day an outcome reported was 
represented an independent observation in the analysis.   
Values for Q statistic with P values < 0.05 were considered as evidence of to 
reject the null hypothesis and conclude that the studies were likely heterogeneous. When 
the P > 0.05 and the null hypothesis was not rejected i.e. studies were homogeneous, the 
summary θ MH and 95% confidence interval of same group of antibiotics with binary data 
was calculated  and for  continuous data the  SMD and 95% confidence interval were 
calculated. Under the fixed effect model it is assumed that the true effect measure is 
shared by each study, and the difference between studies results are due to within study 
variance.  
2
1
( )i i
w
SE θ
=
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Finally, comparisons of antibiotic efficacy were made comparing two data types 
in individual studies, binary data and continuous data of same group of antibiotic studies 
that provided usable information.  The summary effects estimates for binary data were 
expressed as relative risk with 95% confidence interval. If Mantel-Haenszel risk ratio was 
less than one and confidence interval does not include one, interpretation was significant 
reduction in Salmonella shedding. Continuous data were expressed as standardized mean 
difference with 95% confidence interval. A positive SMD and confidence interval does 
not include zero, interpretation was significant reduction of Salmonella shedding.    
  
Results  
In the full review of interventions, 282 publications identified describing multiple 
interventions to reduce Salmonella prevalence in swine. 33 studies described antibiotic 
use to control Salmonella Typhimurium in swine. Four field trials (Funk et al., 2001; 
Nielsen et al., 1997; Roesler U. et al., 2004; Roesler et al., 2005) and 10 challenge trials 
(Abou et al., 1979; Baggesen et al., 1999; Culbreth et al., 1972; Edrington et al., 2001; 
Fenwick and Olander, 1987; Olson et al., 1972; Olson et al., 1977; Olson and Rodabaugh, 
1977; Singh, 1968; Troutt et al., 1974) were excluded from the review based on the 
quality assessment criteria leaving 19 studies to be included in the further consideration. 
Five observational studies describing antibiotic use to control Salmonella are described in 
a separate systematic review and will be published elsewhere. Only fourteen studies, all 
challenge studies, met the quality assessment criteria and data was extracted form these 
studies. Four studies (Ebner and Mathew, 2000; Gutzmann et al., 1976; Jones et al., 1983; 
Williams et al., 1978) included multiple trials, therefore, the 14 studies described 19 
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antibiotic treated and control comparisons. Three studies (Delsol et al., 2003; Ebner and 
Mathew, 2000; Wilcock and Olander, 1978) did not provide enough usable data for the 
meta-analysis i.e. these studies only reported the outcome of significance testing rather 
than group level data with measures of variation (Figure 2).   
The characteristics of 14 challenge studies are summarized in Table 1. Most of the 
studies used commercial pigs as study subjects. The number of animals in treatment 
group varied from 12 to 48. The age of pigs at the start of the antibiotic treatment was 
varied from 3 to 9 weeks, and duration of the studies lasted from 4 weeks to 8 weeks, 
except in one study which lasted 17 weeks in which specific pathogen free (SPF) pigs 
were used. Twelve out of 14 studies were conducted in USA.  
All the studies allocated pigs into treatment and control groups either by simple 
randomization or blocked randomization (Table 2). The most commonly used group of 
antibiotic was the tetracycline group including chlortetracycline, oxytetracycline, and 
tetracycline (Claussen et al., 1998; Delsol et al., 2003; Evangelisti et al., 1975; Gutzmann 
et al., 1976; Jones et al., 1983; Williams et al., 1978)  Four challenge studies  described 
the use of tetracycline in combination with another antibiotic. (Ebner and Mathew, 2000; 
Girard et al., 1976; Gutzmann et al., 1976; Wilcock and Olander, 1978) Two studies 
described the use of bambermycin to reduce S. Typhymurium in swine. (Dealy and 
Moeller, 1976; Letellier et al., 2000) Aminoglycoside, lincosamide, macrolide and 
streptogramin were each only evaluated by a single study (DeGeeter et al., 1976; Jacks et 
al., 1988; Jones et al., 1983; Shryock et al., 1998). Within the same group of antibiotic, 
the sub-therapeutic dose differed from one study to another as did the level of S. 
Typhimurium used per pig for artificial challenge (Table 2).  
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Bacterial culture protocols for isolation and identification of Salmonella were 
differs among studies. Except one, all the other studies were based on 1g of feces. Only 
two studies described the use of pre-enrichment. Selective enrichment and selective 
media with various incubation period and incubation temperature has been used. Studies 
with provided level of detection of Salmonella, varied from 101 cfu/g to 102 cfu/g of feces 
(Table 3).  
 Nine trials from six studies provided continuous data (cfu/g of feces) (Table 4) in 
individual animals for multiple time points, and these data were dichotomized on the 
basis of whether presence or absence of the organism in microbiological culture 
(Evangelisti et al., 1975; Girard et al., 1976; Gutzmann et al., 1976; Jacks et al., 1988; 
Jones et al., 1983; Williams et al., 1978).  One study reported group data (mean cfu/g of 
feces) in antibiotic treated and control groups separately for multiple time points 
(DeGeeter et al., 1976). The other study also reported group data (log mean cfu/g of 
feces) in antibiotic treated and control group for multiple time points (Shryock et al., 
1998). Two studies reported only binary data for multiple time points (Claussen et al., 
1998; Letellier et al., 2000). For all studies with suitable data, the analyses suggested no 
significant statistical heterogeneity between multiple time points in studies for binary and 
continuous outcome (Table 4). Therefore, summary Mantel-Haenszel risk ratio and SMD 
were calculated.  
Three trials reported significant reduction of Salmonella shedding when binary 
data were analyzed (Claussen et al., 1998; Evangelisti et al., 1975; Girard et al., 1976). 
Using continuous data, six trials reported a significant reduction of Salmonella shedding 
(DeGeeter et al., 1976; Evangelisti et al., 1975; Girard et al., 1976; Gutzmann et al., 
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1976; Shryock et al., 1998; Williams et al., 1978), while two trials showed significant 
increases in Salmonella shedding (Jacks et al., 1988; Williams et al., 1978) (Table 4). In 
only two studies was the administration of sub-therapeutic antibiotics associated with 
reduced Salmonella shedding as determined by binary and continuous measures of 
Salmonella (Evangelisti et al., 1975; Girard et al., 1976). 
The assessment of homogeneity between studies using both binary and continuous 
data for the 6 tetracycline group studies showed statically significant evidence of 
heterogeneity (Cochrane Q statistic p value for binary data was 0.000 and for continuous 
data was 0.003). Also, using binary data, there was statistically significant heterogeneity 
in 2 studies of tetracycline with neomycin (Cochrane Q statistic p value for binary data= 
0.000).  There was no evidence to reject the null hypothesis of homogeneity between two 
studies of bambermycin (Cochrane Q statistic p value for binary data was 0.6) (Table 5), 
and therefore summary Mantel-Haenszel risk ratio and 95% confidence interval (0.80, 
0.65 - 0.98) was calculated.  
 
Discussion 
 This systematic review and meta-analysis of the literature aimed to summarize the 
efficacy of antibiotic to reduce S. Typhimurium shedding in market weight finisher 
swine. Based on the quality criteria, only challenge studies were selected for the final 
review as all identified field trials failed to meet the quality assessment criteria, and were 
therefore, excluded from the review. Specifically, all the field trials did not report random 
allocation or blocking of pigs into treatment groups. The principle of randomization is to 
limit the confounding bias (Dohoo I et al., 2003). Our preference would be to report 
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outcomes from field trails as they are thought be better represent the “real world’ 
however, the failure to describe randomization in the study suggests a potential bias and 
we have excluded studies based on this potential bias. 
 The review suggests that antibiotics can be associated with a reduction in 
Salmonella shedding although the effect does not occur for all antibiotics. On one 
occasion, antibiotics were associated with increased shedding.  Further, Salmonella 
reduction is more likely to be detected if a continuous outcome is used rather than binary.  
This finding has implications for assessment of outcomes as it appears that antibiotic 
treatment decreases the amount of Salmonella but not necessarily the number positive 
animals.  For food safety interventions traditionally the assessment has focused on the 
“number of positive pigs”, with the assumption that a reduction in positive pigs would 
translate to reduce Salmonella in pork. The validity of this assumption is unclear.  
However, clearly it is important to consider the outcome that should measure and which 
has the stronger association with food borne disease risk. If binary outcomes are related 
to risk, than only 3 of 12 studies suggest an association, however if continuous data are 
related to risk of 8 of 12 studies suggest as association (positive or negative).  
Unfortunately, one outcome of the review is that we could not identify any studies 
that reported randomization conducted in the population of interest, finisher pigs. 
Although the pigs enrolled for the studies at the age of weaning, the outcome was 
measured before the age of market weight, despite the fact that recommended antibiotic 
withdrawal period before slaughter. Though, these trials were designed to assess the 
efficacy of antibiotic prophylaxis, the length of follow-up has been too short to assess the 
efficacy of antibiotics in market weight swine. Thus, extrapolating beneficial effect of 
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antibiotic use in these studies to market weight finisher swine, if any, is misleading. 
Multidrug resistant S. typhimurium is responsible for 10% - 30% of human salmonellosis 
in United States (Centers for Disease Control and Prevention (CDC), 2006). Prophylactic 
use of antibiotics in feed suppresses the normal intestinal flora of the pig, permitting 
Salmonella to increase in number or to establish a carrier state in the pig, and therefore 
increasing the number of resistant bacteria entering the abattoirs and thereby increasing 
the public health risk through food chain. 
Studies selected for this systematic review has been conducted during the years 
starting from 1975 to 2003, and various culture protocols including pre-enrichment, 
enrichment, selective media, and duration of incubation for Salmonella isolation and 
identification has been practiced.  The only similarity observed in most of these studies 
was the weight of feces used for the culture (Table 3)  
Significant heterogeneity was found between studies of tetracycline, and studies 
of tetracycline with neomycin (Cochrane Q p value <0.05) (Table 5). It is possible that 
lack of consistency among study protocol, and different levels of detection contributed to 
the heterogeneity between outcomes of studies of same group of antibiotics. It was not 
possible to investigate sources of variation, although, sub-group analysis and meta-
regression methodology exist to investigate the sources of variation (Egger et al., 2001). 
The summary M-H RR estimate of two studies describing bambermicin use in 4 -9 weeks 
old swine was 0.8 (confidence interval 0.65 to 0.98) in antibiotic treated group compared 
to control group (Figure 1). Although, the summary estimate suggests a 20% reduction in 
Salmonella shedding, the power of this estimate is limited as only two have contributed 
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information and the number animals included in antibiotic intervention and control 
groups were very low.    
This review has several strengths. Comprehensive search for literature by 
exploring thirteen electronic databases and by hand searching three conferences 
proceedings relevant to the review topic captured all possible published literature. This 
comprehensive literature search minimized the possibility of publication bias. Screening 
for studies was conducted independently by two reviewers, as was quality assessment of 
included studies, and disagreements were resolved with discussion to minimize the 
reviewer bias, and conducted this systematic review and meta-analyses in accordance 
with published guidelines (Sargeant et al., 2006). In interpreting these results, some of the 
limitations of these studies must be taken into consideration. Assumption of 
independence of outcome measured in multiple time points is another concern. Finally, it 
is important to bear in mind that given the lack of relevance of these challenge studies to 
the natural infection under field conditions in finisher swine, no absolute conclusion can 
be drawn from this systematic review on the efficacy of antibiotic to reduce Salmonella 
shedding in market weight finisher swine (Griffith et al., 2006).  
Other potential biases also have to be considered. We have restricted our review 
to articles published in English, because of the logistic difficulties of translation from 
other languages. We excluded trials that were only reported in abstract form, because of 
the impossibility of extracting the data for meta-analysis. To avoid potential biases, an 
adequate methodology must be used in designing field trials, including the definition of 
primary objective, a priori statistical evaluation of the number of animals to be included, 
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description of the randomization method and allocation concealment, and description of 
the blinding at outcome measure  
In conclusion, from the available literature, although some antibiotics reduced the 
Salmonella shedding in swine in these challenge studies, extrapolation of these findings 
to finisher swine is not recommended. 
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Table 1: Country, type of animal and number of animals used for the trial, age or weight 
at the enrollment, and study period for the challenge studies describing S. typhimurium 
measured by culture   
Study Country Type of pig 
production  
Total N* Age or weight 
at enrollment 
Study 
period 
in days 
Claussen et al., 1998  USA Commercial 20 at weaning 35 
Dealy et al., 1976 USA Commercial 20 4 to 5 weeks 49 
DeGeeter et al., 1976 USA Commercial 19 4 to 5 weeks 53 
Delsol et al., 2003 UK Commercial 12 3 weeks 41 
Ebner et al., 2000 USA Experimental 48 3 weeks 84 
Evangelisti et al., 1975 USA Commercial 20 9.6 kg 28 
Girard et al., 1976 USA Commercial 20 9.1 kg 28 
Gutzmann et al., 1976 USA Experimental 30 5 to 6 weeks 26 
Jacks et al., 1988 USA Commercial 20 6 to 7 weeks 56 
Jones et al., 1983 USA Commercial 12 6 weeks 31 
Letellier et al., 2000 Canada Commercial 20 12 days 28 
Shryock et al., 1998 USA Commercial 20 7 weeks 57 
Wilcock et al., 1978 USA SPF** 20 Weaned 120 
Williams et al., 1978 USA Commercial 14 8-18kg 57 
 
*
 Total N represent only the number of animals in treatment group (challenged with 
Salmonella and antibiotic treated) and control group (challenged with Salmonella only)  
 
** Specific pathogen free 
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Table 5. Heterogeneity investigation between same family of antibiotic studies using 
binary and continuous data under fixed effect model 
  
Binary data Continuous data 
Antibiotic group 
Number of  
Studies 
Number of 
time points 
Cochrane Q 
p value 
Number of 
time points 
Cochrane Q 
p value 
Tetracycline 6 73 0.000 38† 0.003 
Tetracycline & Neomycine 2 11 0.000 * * 
Bambermycine 2 15 0.6 *   * 
      
†
 Number of time points for continuous data represents only from 5 studies   
*
 No continuous data available 
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Figure 1. Flow chart of study selection process  
Potentially relevant studies identified 
and screened for relevance (7738) 
Excluded non relevant 
references (7456)
Studies retrieved for quality assessment 
of studies for all interventions (282)
Potentially appropriate studies to be 
included in the meta-analysis (19)
Number of studies included in the 
systematic review  (14)
Excluded observational 
studies (5)
Excluded with reasons 
(14)
Studies retrieved describing antibiotic as 
an intervention (33)
Studies with usable information  (11)
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CHAPTER 5 
 EVALUATING THE SENSITIVITY AND SPECIFICITY OF CULTURE AND 
PCR METHODS FOR DETECTION OF SALMONELLA IN FIELD SAMPLES 
USING THE STARD APPROACH  
T. N. Denagamage  
 
INTRODUCTION  
 In response to the ongoing United States Department of Agriculture-Food Safety 
and Inspection Service (USDA-FSIS) national initiative to reduce human salmonellosis 
by 50% there is a need to develop rapid, economical, and simple techniques for detection 
and ultimately enumeration of Salmonella in order to assess the effectiveness of Hazard 
Analysis and Critical Control Point (HACCP) interventions as well as to support on-
going surveillance. Surveillance, therefore, requires a rapid, user-friendly method to 
accurately monitor a large number of samples with potentially low Salmonella 
prevalence.  
Detection of Salmonella in pork products and porcine lymph nodes employs 
bacteriological isolation, which entails multiple sample transfers to multiple culture 
media. This process is time-consuming, prone to laboratory cross-contamination, and 
requires an experienced microbiologist to perform the test. PCR-based technologies may 
represent a technology that could be rapid and inexpensive and applied to Salmonella 
surveillance within the plant. The aim of this study was to evaluate a PCR for detection 
of Salmonella in field samples. As field samples were used, no gold standard test was 
available; therefore, Bayesian approaches to data analysis were used. Further, the design 
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of the study followed the principles of the standards for reporting of diagnostic accuracy 
(STARD) statement which aims to minimize the bias in reporting of sensitivity and 
specificity of diagnostic assays.  
 
MATERIALS AND METHODS 
 In this study, the STARD checklist was used to report the assessment of 
sensitivity and specificity of PCR and culture methods for Salmonella detection in field 
samples (7,8). 
Samples were collected from pigs slaughtered at a large scale abattoir in mid-west 
United States. The capacity of the abattoir was 2600 pigs per hour. All the pigs included 
in the study were finished on farms in Iowa. Transport time from farm to abattoir varied 
up to 3 hours, and lairage time varied to 2 hours from overnight.  For the study, finisher 
pigs from 15 farms were selected, and collected on 15 sampling days during the period 
from July 2007 to December 2007. At each farm, 30 pigs were selected based on 
convenience and tattooed.  At the slaughter plant, sub-iliac and mesenteric lymph nodes 
were collected. Mesenteric lymph nodes were collected from the gastro-intestinal viscera 
after evisceration and separation from the carcass. The sub-iliac lymph nodes were 
collected before chilling. The sub-iliac lymph nodes were identified at the individual 
animal level by a code comprising tattoo number of the pig. Mesenteric lymph node 
samples were separated from the carcass and therefore could only be identified at the 
farm level. Therefore, it was not possible to match sub-iliac and mesenteric lymph nodes 
at the individual animal level.          
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Mesenteric lymph nodes and sub-iliac lymph nodes were collected into labeled 
sterile plastic bags (Whirl-Pak bag, Fisher Scientific Inc) using sterile forceps and 
scissors. Samples were transported at ambient temperature to the laboratory within 2 
hours of collection and stored at 4º C. 
Using sterile forceps, the lymph node was removed from the whirl top bag and 
dipped in 70% ethanol, and briefly flamed.  The flamed lymph node was placed in an 
appropriately labeled filter bag and macerated with a rubber mallet. 25 ml sterile 
phosphate-buffered saline was added to the macerated lymph node and the sample was 
stomached for 60 seconds at 230 rpm to create a lymph node homogenate for the 
bacterial culture and for the PCR assay. All mesenteric and sub iliac samples were 
processed immediately using culture, and homogenates were stored for later PCR 
analysis.  Homogenates of mesenteric lymph node samples and sub-iliac lymph node 
samples were randomly selected (Microsoft Office Excel 2003) from the stored 
homogenates for real-time PCR assay.  
Culture procedure was conducted by a research associate with a Master of Science 
with a microbiology emphasis. 
Two pre-enrichments; tetrathionate (TT) broth and buffered-peptone water (BPW) 
were used to culture Salmonella. For TT broth pre-enrichment, 10 ml of lymph node 
homogenate was added into 90 ml TT broth, and incubated 48 hours at 37º C. For BPW 
pre-enrichment, 10 ml lymph node homogenate sample was added into 90 ml BPW, and 
incubated for 24 hours at 42º C. After incubation, 100 µl of TT broth and 100 µl of BPW 
were inoculated into appropriately labeled tubes containing 10 ml Rappaport-Vassiliadis 
R 10 (RV) broth, and incubated for 24 hours at 42º C. After incubation, the RV tubes 
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were vortexed and streaked for isolation of Salmonella onto Xylose-Lysine-Tergitol-4 
(XLT-4) agar and Brilliant Green Sulfa (BGS-N) plates, and incubated for 48 – 72 hours 
at 37º C.  Suspected Salmonella colonies were inoculated into Triple Sugar Iron (TSI) 
agar and Lysine Iron agar (LIA), and inoculated for 24 hours at 37 0C. Agglutination tests 
were carried out on positive samples using Salmonella O antiserum poly A-I and Vi 
(Figure 1). The results of culture were classified as positive or negative, without any 
quantification of the number of Salmonella recovered.  
For quality assessment and control, the sets of lymph node homogenate samples 
were concurrently cultured with one known positive sample containing with Salmonella 
enterica 1 colony forming units (cfu)/g, one negative sample, and one unknown sample 
either inoculated with Salmonella enterica 1 cfu/g or not-inoculated. During the period of 
the study the results of the quality control for known and unknown samples was 100% 
correctly identified. Bacterial culture procedure was associated with a quality control 
measures. In a quality control studies conducted by the laboratory 6 months prior to the 
initiation of this study, the detection limit of the reference culture method for Salmonella 
enterica was 1 cfu/g in ground pork.  Ground pork was used for these baseline studies as 
large quantities of lymph nodes were not readily available. The Salmonella used for the 
detection limit study was obtained from Curt Thompson of Veterinary Diagnostic 
Laboratory, College of Veterinary Medicine, Iowa State University. The minimum 
detection limit for bacterial culture protocol was 1 cfu/ml.   
After random selection of homogenates for analysis using the index test, these 
samples were submitted and evaluated for Salmonella. Real-time PCR was conducted by 
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a molecular microbiologist trained by a PhD in microbiology, blinded to the culture test 
results and the prevalence of positive samples in the sample set. 
Total genomic DNA from mesenteric and sub-iliac lymph node homogenate 
samples prior to enrichment was extracted by Ambion® MagMAXTM isolation kit 
according to the manufacturer's instructions (Cat. AM1840; Austin, Texas). Briefly, 
lymph node homogenate samples were centrifuged at 100 x g for 1 minute at 4º C to 
remove tissue debris. A 175 µl volume of supernatant was transferred to a bead tube 
containing 235 µl of lysis binding solution. Then, the samples were bead-beated for 5 
minutes at 20 Hz on a tissue lyser (Qiagen Valencia, CA) to lyse the bacteria to release 
nucleic acid by physical disruption with the zirconia beads. Later, the beads were pelleted 
by centrifugation at 16,000 x g for 6 minutes. After centrifugation, 115 µl of each sample 
was used for subsequent nucleic acid purification. Nucleic acid purification procedure, 
which involved different washing, binding and elution steps, was performed on 96-well 
plates using a KingFisher® 96 Magnetic Particle Processor (Thermo Scientific, Waltham, 
MA).   
Real time PCR for the detection of Salmonella in swine lymph node samples 
collected at the abattoir were carried out according to the method described previously 
(19). This assay targeted Salmonella enterotoxin stn gene. Cutoff value and threshold 
level were set at 40 cycles and 0.1, respectively. Minimum detection limit was 50 cfu/ml 
for real-time PCR.   
Approximately, 400 samples are required from both populations to be tested with 
95% probability that Salmonella would be detected in sub-iliac lymph nodes if the true 
prevalence is greater than or equal to 1%, and in mesenteric lymph nodes if the true 
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prevalence is greater than or equal to 42% (Table 1). Sample size calculations were 
performed using the free source software (1) based on the sensitivity and specificity of 
culture method at 93% and 99% respectively, and sensitivity and specificity for real time 
PCR expected to be at 99% respectively . Preliminary data showed that the Salmonella 
prevalence in mesenteric lymph nodes to be 42%. Salmonella prevalence in sub-iliac 
lymph nodes was expected to be 1% (personal communication Dr. Annette O’Connor and 
Dr. James McKean) 
For the statistical analysis, Bayesian modeling approaches were used to estimate 
diagnostic sensitivity and specificity of the reference and index test. Two models were 
constructed. 
 The 1st analysis involved a test for sensitivity and specificity using data from two 
populations (mesenteric and sub-iliac lymph nodes) without a gold standard test 
assuming dependence between the outcomes of the index and reference tests (10). The 
analysis assumed that the index and reference outcomes for a given sample are correlated 
because both tests were testing for similar biological phenomenon. Further, this analysis 
assumed that sensitivity and specificity of PCR and culture remains the same in both 
lymph node populations.      
The models were run using the freeware program WinBUGS (22). Posterior 
estimates were obtained on 100,000 iterations of the Gibbs sampler with a burn-in phase 
of 500 iterations. The median of the posterior distribution was used for the point estimate 
with 95% probability intervals. Assessment of convergence was determined by 
examining trace plot and history plot to allow using the posterior distribution produced 
by Gibbs sampling. 
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 We refer to index test (real-time PCR) as T1 and reference test (bacterial culture) 
as T2. The formulas used for determination of sensitivity and specificity are provided 
below.  
Let T+ and T- denote positive and negative test results, respectively, and let D+ 
and D- denote infected and non-infected animals, respectively. Sensitivity and specificity 
of test be designated by Se and Sp, respectively, and prevalence is denoted by π.  
The model includes two prevalence (one for each population),  
(Se11, Se12, Se21, Se22) and (Sp11, Sp12, Sp21, Sp22), where 
 Se11 = P(T1+, T2+|D+) 
 Se12 = P(T1+, T2-|D+) 
 Se21 = P(T1-, T2+|D+) 
 Se22 = P(T1-, T2-|D+) 
and  
 Sp11 = P(T1+, T2+|D-) 
 Sp12 = P(T1+, T2-|D-) 
 Sp21 = P(T1-, T2+|D-) 
 Sp22 = P(T1-, T2-|D-) 
Therefore, the conditional correlation between the two test outcomes for an infected and 
non-infected animal is given by,  
 ρD+ = 11 1 2
1 1 2 2(1 ) (1 )
Se Se Se
Se Se Se Se
−
− −
 
and  
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 ρD- = 22 1 2
1 1 2 2(1 ) (1 )
Sp Sp Sp
Sp Sp Sp Sp
−
− −
 
respectively. Accounting for the correlation between test results for a given animal, 
estimates of the Se1, Se2, Sp1, Sp2 are; 
 Se1 = Se11 + Se12 
 Se2 = Se11 + Se21 
 Sp1 = Sp22 + Sp21 
 Sp2 = Sp22 + Sp12 
For the Bayesian analysis, beta prior distributions were constructed using beta 
buster software (17). The mode of the beta distribution is given by the formula (a -1) / (a 
+ b – 2), where, for example if an experiment resulted in “s” number of test-positive 
animals in “n” number of truly infected animals, use of a beta (a, b) distribution with a = 
s+1 and b = n-s+1 is recommended as an appropriate choice to model the uncertainty in 
that parameter (17).  
Estimates of the sensitivity and specificity of the index and reference tests for the 
beta prior distributions based on previous published data or expert opinion. Salmonella 
prevalence in mesenteric lymph nodes (population 1) has been estimated in a previous 
study to be 9.1% (95% CI 5.8 to 12.4) (18), therefore, the best value of 0.1, and we 
assumed that it should not be more than 0.5 with 95% certainty was used. Prevalence 
estimate for Salmonella in sub-iliac lymph nodes believed to be considerably lower than 
the mesenteric lymph nodes based on expert opinion. Therefore, the most probable value 
of 0.01 and 95th percentile of 0.3 was used (Personal communication Dr. James McKean 
and Dr. Annette O’Connor). Sensitivity and specificity for bacterial culture were 
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constructed based on a previous study that has used the culture protocol used in the 
laboratory. If the most probable value for sensitivity at 1 cfu/g level was set at 0.95 and 
more than 0.7 with 95% certainty, and prior mode for specificity be of 0.98 and 5th 
percentile of 0.7 (21). As the real-time PCR was a new test and lack of knowledge about 
parameters, we expected at least sensitivity and specificity that match with bacterial 
culture, therefore, diffuse beta distributions were used. Prior mode for PCR sensitivity 
was 0.9 and specificity was 0.95 with 5th percentile of 0.1 for both parameters (Table 2).    
If the model for two dependent tests for two populations without a gold standard 
test estimated no correlation within the infected and/or non-infected sub-populations, as 
shown by a correlation measure with a 95% probability interval that included zero, then a 
second analysis was conducted assuming independence.  The secondary analysis 
assumed, the two test outcomes for a given sample were independent (11).   
 The influence of the prior distributions on the posterior estimates of the model 
parameters were assessed by using relatively non-informative priors for the culture 
sensitivity and specificity. Thus, for sensitivity and specificity of the bacterial culture, 
uniform beta prior distributions (1) were used. Finally, influence analysis was conducted 
with perturbed data to determine the impact of analysis on the inference.  
The results of the models were reported as sensitivity, specificity of the index and 
reference tests, expected prevalence in the two populations and corresponding 95% 
probability intervals.  
Reproducibility of real-time PCR assay was evaluated by testing half of the 
samples listed under each cell of the 2 x 2 table that describes the cross-classified test 
results from bacteriology culture and initial real-time PCR (Table 3). Real-time PCR was 
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conducted by the same molecular microbiologist using the same protocol that used for the 
initial PCR assay. Results of the first PCR assay were blinded to the microbiologist.  
    
RESULTS  
It was not possible to obtain the desired sample size, and only 170 samples were 
used for the study.  Cross classified data for study one are given in a contingency table 
(Table 3). In total, 168 MLN and 169 SILN were tested for Salmonella using bacterial 
culture and in-house real-time PCR methods. Two MLN samples and one SILN sample 
were missing and therefore, excluded from PCR assay. Cross-classified results of initial 
PCR and second PCR are given in Table 4. For sub-iliac lymph nodes, of the 20 samples 
that were positive for the initial PCR only two samples gave positive results on re-test, 
and whereas of 65 samples that were negative by the initial PCR only 51 samples were 
negative results by the re-test. For the mesenteric lymph nodes, out of 22 samples 
positive for first PCR (7 culture positive and 15 culture negative) only 7 were positive by 
the second PCR while of the 59 that were negative by the initial PCR (13 culture positive 
and 46 culture negative) only 44 samples were detected as negative on re-test. 
 The dependence model estimated negligible correlation between the index and 
reference tests (less than 0.2) for positive samples -0.08 (-0.42, 0.23) and for negative 
samples 0.02 (-0.04, 0.16), therefore, the secondary analysis assuming independence was 
conducted. The parameter estimates for sensitivity and specificity of bacterial culture and 
real-time PCR were consistent between dependence model and independence model. 
Better convergence was observed in the independence model. This determination of 
better convergence was based on trace plot and probability interval for culture sensitivity 
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in two independent tests was slightly narrower than the two dependant tests. The 
estimated Salmonella prevalence in mesenteric lymph nodes was similar in both models 
i.e. 0.29 (0.21, 0.39) and 0.29(0.21, 0.41). The estimated Salmonella prevalence in sub-
iliac lymph node was 0.002 (0.0002, 0.02) in two dependent tests while it was negligible 
or zero in independence model 0.0 (0.0, 0.01).  
  Based on the test results obtained for 166 samples selected for the second PCR, 
Bayesian estimates of sensitivity and specificity were, 0.37 (0.18, 0.59) and 0.76 (0.68, 
0.82), respectively, for the initial real-time PCR assay, and 0.42 (0.23, 0.64) and 0.79 
(0.72, 0.86), respectively, for the re-test PCR assay. The level of agreement between 
initial and re-test PCR were 0.6 for both sub-iliac lymph nodes and mesenteric lymph 
nodes.  
 
DISCUSSION  
Reproducibility of the results of real-time PCR was poor, and this in turn 
adversely influence the diagnostic test accuracy of this PCR. Although the estimates of 
the sensitivity and specificity were reasonably similar for the two PCR runs, the 
individual samples showed little agreement (kappa=-0.1). This made it impossible to 
conduct a meaningful statistical analysis as the results were not reproducible, an essential 
element in any diagnostic test evaluation.  The study shows the value of following 
STARD guideline to assess a diagnostic outcome.  
The reasons the PCR was not repeatable may be due to two fold. False positive 
results may be due to cross reactions and can be prevented by application of appropriate 
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laboratory operation procedure and optimization of the assay. False negative results were 
of special concern during this study, may be due to potential inhibitory substances.  
The study design could have been improved by changing the protocol used for the 
sample preparation and testing procedure for culture and PCR. Since the study was 
designed to test the samples once for culture and PCR, no samples left for re-testing both 
culture and PCR assay. Therefore, it was able to re-test only PCR assay. If the study 
design included blinded multiple testing of same samples at once or re-testing for both 
tests later, we would be able test the repeatability of both tests.   
In conclusion, test sensitivity and specificity estimates of bacterial culture and 
PCR assay to detect Salmonella in field samples may not be valid since it was unable to 
reproduce both tests.   
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Table 1. Sample size estimates for two populations with different prevalence levels  
  Prevalence in population two 
Prevalence in population one 5% 1% 0.5% 
50% 413 409 409 
40% 407 401 401 
30% 375 364 362 
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Table 2. Beta-prior distributions obtained from beta-buster software for parameters in 
studies one and two 
Parameter 
Median (95% 
probability intervals) 
Study 1 
P1
 
 0.01 (0.003 ; 0.353) 
P2 0.1(0.018 ; 0.564) 
Se1 0.95 (0.652 ; 0.990) 
Sp1 0.98 (0.647 ; 0.995) 
Se2 0.9 (0.059 ; 0.978) 
Sp2 0.95 (0.058 ; 0.979) 
Study 2 
P3 0.2 (0.054 ; 0.551) 
Se1 0.95 (0.652 ; 0.990) 
Sp1 0.98 (0.647 ; 0.995) 
Se3 0.98 (0.647 ; 0.995) 
Sp3 0.98 (0.647 ; 0.995) 
(Prevalence of Salmonella in sub-iliac lymph nodes (P1) and mesenteric lymph nodes 
(P2), and sensitivity (Se1) and specificity (Sp1) of bacterial culture, and sensitivity (Se2) 
and specificity (Sp2) of real-time PCR in study one. Prevalence (P3) of Salmonella in 
belly flaps skin, and sensitivity (Se1) and specificity (Sp1) of bacterial culture, and 
sensitivity (Se3) and specificity (Sp3) of BAX-system PCR in study two). 
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Table 3. Cross-classified test results from bacteriology culture and real-time PCR for 
Salmonella in swine carcass lymph nodes (Study 1) 
 Sub-iliac lymph node 
 PCR Positive PCR Negative 
Culture Positive 0 0 
Culture Negative 40 129 
 Mesenteric lymph node 
 PCR Positive PCR Negative 
Culture Positive 16 29 
Culture Negative 29 94 
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Table 4. Cross-classified test results to illustrate the reproducibility of real-time PCR with 
166 samples for Salmonella in swine carcass lymph nodes (Study 1)  
 Sub-iliac lymph node 
 PCR1 Positive PCR1 Negative 
PRC2 Positive 2 14 
PCR2 Negative 18 51 
 Mesenteric lymph node 
 PCR1 Positive PCR1 Negative 
PCR2 Positive 7 15 
PCR2 Negative 15 44 
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Figure 1. Flow diagram of the study to illustrate the bacterial culture protocol and PCR 
procedure for study 1 
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Figure 2. Flow diagram of the study to illustrate the culture protocol and PCR procedure 
for study 2 
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GENERAL CONCLUSION 
 
Evidence-based medicine (EBM) is an approach in human medicine that requires 
the conscientious, explicit and judicious use of current best evidence in making decisions 
about the care of individual patients.  Although this concept has been used in human 
medicine over the last two decades, its application to veterinary science is still in infancy.  
A tremendous effort has been put forth towards controlling Salmonella in animal 
production systems as a food-borne pathogen.  However, no evidence-based approach has 
been applied to evaluate the best available control and intervention strategies to control 
Salmonella in swine. In this dissertation, an evidence-based approach was pursued to 
study food safety issues associated with Salmonella in swine.  
The 1st study in the thesis evaluated using EBM concepts vaccination as a method 
to control Salmonella in swine.  To achieve this objective, a systematic review was 
conducted on available literature to select high quality studies.  However, only a 
qualitative analysis could be carried out due to the lack of quantitative data.  This study 
indicated that the quality of available research is poor. The 2nd study applied EBM 
principles to determine whether antibacterial therapy has any effect on control of 
Salmonella in swine by applying a quantitative analysis on available research related to 
the subject.  The analysis of binary and continuous data of studies showed no similarity 
of efficacy of antibiotics.  Specifically, this study tried to apply the concept of meta-
analysis and evaluate varying outcomes to determine efficacy. The third study was aimed 
was to identify a rapid and sensitive detection method for Salmonella screening in swine 
using field samples.  Here, the in-house Salmonella culture protocol was compared with 
  
131 
two PCR assays conducted by two laboratories; a real-time PCR method and a BAX PCR 
method.  Results obtained with in-house culture method was compared with different 
PCR assays in two different studies using the Bayesian methodology to determine the 
sensitivity and specificity of PCR assays without a gold-standard test. Interestingly, the 
culture method showed the same sensitivity and specificity in both studies indicating it as 
a robust diagnostic approach.  Further, BAX system PCR gave promising sensitivity and 
specificity, but the sensitivity and specificity of real-time PCR was low.  
Overall, the work conduct for this thesis identified problems during application of 
evidence-based medicine to veterinary science and food safety aspects.  Most studies are 
poor in quality and fell into the lower levels of the evidence pyramid. Randomized-
clinical trials, the best study design for evidence-based medicine, are not widely carried 
out in veterinary research due to the constraints such as financial restrictions, practical 
issues and other logistics.  Although in human medicine, evidence-based medicine is 
applied to make decisions about individual patient outcomes, this study was conducted to 
make informed decisions on Salmonella control in swine on population basis with the 
aim of reducing food-borne salmonellosis in humans but EBM principles could not be 
directly applied.   
This thesis highlighted difficulties of applying EBM to food safety. If EBM was 
applied it in purest form, the thesis would conclude that no high quality field studies 
existed that describe vaccination and sub-therapeutic antibiotic use to reduce Salmonella 
in the pre-harvest area of swine production.  However, decisions do need to be made, 
even in the absence of high quality information, and it is difficult to “throw out” all the 
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information available.  The dilemma for EBM proponents is whether to dismiss all 
evidence that is not high quality and risk appearing irrelevant, or to lower the standards 
and abandon the idea that some information is better quality.  In the short term, lowering 
the standards and presenting the result of lower quality studies as the best available seems 
an easier path, however, will this really more food safety and veterinary science.  In 
human medicine, the quality of reporting has been improved in many areas because 
studies are excluded when poorly conducted and reported, this change in quality is 
obviously needed in food safety and will only occur if authors feel pressured to improve.  
Reporting the summarized results from poorly reported studies in systematic reviews will 
not apply similar pressure to food safety researchers.  
Despite this challenge, the conclusion reached is that application of evidence-
based medicine to veterinary science has its own merits, but is an evolving area and direct 
application of all topics from human EBM to veterinary / food safety EBM will require 
more experience. Evidence-based approach for veterinary science and food safety 
interventions are useful and we should strive to give consumers the same level of 
scientific confidence in food safety related decisions as patient treatment decisions 
because this methodology assures that on the science about a topic is transparently 
presented, and ensures up to date and reliable information for researchers, veterinarians, 
producers, and finally, for consumers.  Decision makers can then consider societal and 
economics issues, as well as scientific findings, to make the final determination of what is 
best.   
 
  
133 
ACKNOWLEDGMENTS 
 
I am deeply grateful to my major professor, Dr. Annette O’Connor, for her 
advice, support and direction given throughout the study program. Her wide knowledge 
and her logical way of thinking have been of great value for me. I would also like to 
thank other members of the committee, Dr. Scott Hurd and Dr. James Dickson, for their 
thoughtful suggestions and constructive comments which strengthened my research.  
I am forever indebted to my wife, Subhashinie Kariyawasam for her unflagging 
love, understanding and unwavering support throughout my career. I also wish to give 
my appreciation and love to my two children, Sachira and Prabhavi, for their love and 
forbearance. 
My deepest gratitude goes to my parents, sisters and brothers, especially to my 
elder brother, Gunadasa, for being unconditionally supportive of me and always having 
faith in my abilities. My special thanks are also due to my mother-in-law and father-in-
law for their understanding and caring support.  
 
  
